<SEC-DOCUMENT>0001104659-22-066648.txt : 20220531
<SEC-HEADER>0001104659-22-066648.hdr.sgml : 20220531
<ACCEPTANCE-DATETIME>20220531170447
ACCESSION NUMBER:		0001104659-22-066648
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		20
CONFORMED PERIOD OF REPORT:	20220526
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220531
DATE AS OF CHANGE:		20220531

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ClearSign Technologies Corp
		CENTRAL INDEX KEY:			0001434524
		STANDARD INDUSTRIAL CLASSIFICATION:	INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL [3823]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			WA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35521
		FILM NUMBER:		22984437

	BUSINESS ADDRESS:	
		STREET 1:		8023 E. 63RD PLACE, SUITE 101
		CITY:			TULSA
		STATE:			OK
		ZIP:			74133
		BUSINESS PHONE:		(918) 236-7770

	MAIL ADDRESS:	
		STREET 1:		8023 E. 63RD PLACE, SUITE 101
		CITY:			TULSA
		STATE:			OK
		ZIP:			74133

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CLEARSIGN COMBUSTION CORP
		DATE OF NAME CHANGE:	20080507
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2217097d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:clir="http://clearsign.com/20220526">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_03E_clir_clearsign.com_20220526 -->
<!-- Field: Set; Name: xdx; ID: xdx_048_20220526_20220526 -->
<!-- Field: Set; Name: xdx; ID: xdx_056_edei%2D%2DEntityCentralIndexKey_0001434524 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-05-26to2022-05-26" name="dei:EntityCentralIndexKey">0001434524</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-05-26to2022-05-26" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="clir-20220526.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-05-26to2022-05-26">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001434524</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-05-26</xbrli:startDate>
        <xbrli:endDate>2022-05-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WASHINGTON, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_903_edei--DocumentType_c20220526__20220526_z24zwbYgGYi3"><ix:nonNumeric contextRef="From2022-05-26to2022-05-26" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 or 15(d) of the</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Date of report (Date of earliest event reported):
<span id="xdx_905_edei--DocumentPeriodEndDate_c20220526__20220526_zzMWac56FAf9"><ix:nonNumeric contextRef="From2022-05-26to2022-05-26" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">May 26, 2022</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_904_edei--EntityRegistrantName_c20220526__20220526_zYwa4Bf3Do98"><ix:nonNumeric contextRef="From2022-05-26to2022-05-26" name="dei:EntityRegistrantName">CLEARSIGN TECHNOLOGIES CORPORATION</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Exact name of registrant as specified in Charter)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr>
    <td style="vertical-align: top; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_903_edei--EntityIncorporationStateCountryCode_c20220526__20220526_zGcb0nr87Jt7"><ix:nonNumeric contextRef="From2022-05-26to2022-05-26" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Washington</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; width: 2%">&#160;</td>
    <td style="vertical-align: top; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90D_edei--EntityFileNumber_c20220526__20220526_ztUYCLUy3Ft3"><ix:nonNumeric contextRef="From2022-05-26to2022-05-26" name="dei:EntityFileNumber">001-35521</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; width: 2%">&#160;</td>
    <td style="vertical-align: top; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90F_edei--EntityTaxIdentificationNumber_c20220526__20220526_zyJpgbeJzL4" style="font-size: 10pt"><ix:nonNumeric contextRef="From2022-05-26to2022-05-26" name="dei:EntityTaxIdentificationNumber">26-2056298</ix:nonNumeric></span></b></span></td></tr>
  <tr>
    <td style="vertical-align: top">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(State or other jurisdiction of</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>incorporation or organization)</b></p></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Commission File No.)</b></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(IRS Employee
    <br />
Identification No.)</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_908_edei--EntityAddressAddressLine1_c20220526__20220526_z3KtDtBDUQA7"><b><ix:nonNumeric contextRef="From2022-05-26to2022-05-26" name="dei:EntityAddressAddressLine1">8023
E. 63<sup>rd</sup> Place</ix:nonNumeric></b></span><b>, <span id="xdx_90B_edei--EntityAddressAddressLine2_c20220526__20220526_zJhmElqEOBdl"><ix:nonNumeric contextRef="From2022-05-26to2022-05-26" name="dei:EntityAddressAddressLine2">Suite 101</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_906_edei--EntityAddressCityOrTown_c20220526__20220526_zBniUOM28PLd"><ix:nonNumeric contextRef="From2022-05-26to2022-05-26" name="dei:EntityAddressCityOrTown">Tulsa</ix:nonNumeric></span>, <span id="xdx_906_edei--EntityAddressStateOrProvince_c20220526__20220526_zYtwLgRqRotj"><ix:nonNumeric contextRef="From2022-05-26to2022-05-26" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">Oklahoma</ix:nonNumeric></span> <span id="xdx_90A_edei--EntityAddressPostalZipCode_c20220526__20220526_zDlEYPD7oiJl"><ix:nonNumeric contextRef="From2022-05-26to2022-05-26" name="dei:EntityAddressPostalZipCode">74133</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Address of Principal Executive Offices)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90E_edei--CityAreaCode_c20220526__20220526_z8VTs5u4Eo6g"><ix:nonNumeric contextRef="From2022-05-26to2022-05-26" name="dei:CityAreaCode">206</ix:nonNumeric></span>-<span id="xdx_901_edei--LocalPhoneNumber_c20220526__20220526_zwhh5NvTbpAa"><ix:nonNumeric contextRef="From2022-05-26to2022-05-26" name="dei:LocalPhoneNumber">673-4848</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Issuer Telephone number)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions (see General Instruction A.2 below).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font: 10pt Wingdings"><span id="xdx_90F_edei--WrittenCommunications_c20220526__20220526_zr6wg3m8fM99"><ix:nonNumeric contextRef="From2022-05-26to2022-05-26" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font: 10pt Wingdings"><span id="xdx_90C_edei--SolicitingMaterial_c20220526__20220526_zirQ31ygkvI9"><ix:nonNumeric contextRef="From2022-05-26to2022-05-26" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font: 10pt Wingdings"><span id="xdx_907_edei--PreCommencementTenderOffer_c20220526__20220526_zEhxJSAq6JH1"><ix:nonNumeric contextRef="From2022-05-26to2022-05-26" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font: 10pt Wingdings"><span id="xdx_90D_edei--PreCommencementIssuerTenderOffer_c20220526__20220526_zcWvhYK9aHk6"><ix:nonNumeric contextRef="From2022-05-26to2022-05-26" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Pre-commencement communications pursuant to Rule 13e-(c) under the Exchange Act (17 CFR 240.13(e)-4(c)).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 100%; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">Emerging growth
    company </span><span id="xdx_901_edei--EntityEmergingGrowthCompany_c20220526__20220526_zpvib8xilWY2" style="font: 10pt Wingdings"><ix:nonNumeric contextRef="From2022-05-26to2022-05-26" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></td>
    </tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">If an
emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-family: Wingdings">&#168;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; width: 34%; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Title of each class</b></span></td>
    <td style="width: 1%; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 32%; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Trading Symbol(s)</b></span></td>
    <td style="width: 1%; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 32%; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Name
    of each exchange on which registered</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt"></td>
    <td style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt"></td>
    <td style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt"></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90C_edei--Security12bTitle_c20220526__20220526_z2yUOXpZa2ek"><ix:nonNumeric contextRef="From2022-05-26to2022-05-26" name="dei:Security12bTitle">Common Stock</ix:nonNumeric></span></b></span></td>
    <td style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90D_edei--TradingSymbol_c20220526__20220526_zvBf4QHVShPf"><ix:nonNumeric contextRef="From2022-05-26to2022-05-26" name="dei:TradingSymbol">CLIR</ix:nonNumeric></span></b></span></td>
    <td style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90F_edei--SecurityExchangeName_c20220526__20220526_zaHr67Y5oxbf"><ix:nonNumeric contextRef="From2022-05-26to2022-05-26" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">The Nasdaq Stock Market LLC</ix:nonNumeric></span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>Item 1.01. Entry into
a Material Definitive Agreement </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><i>Entry into Underwriting Agreement
</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>





<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On May 27, 2022,
ClearSign Technologies Corporation (the &#8220;Company&#8221;) entered into an underwriting agreement (the &#8220;Underwriting
Agreement&#8221;) with Newbridge Securities Corporation (the &#8220;Underwriter&#8221;), relating to a firm commitment underwritten
public offering (the &#8220;Offering&#8221;), for the issuance and sale of 3,640,000 shares (the &#8220; Firm Shares&#8221;) of the
Company&#8217;s common stock, par value $0.0001 per share, at a public offering price of $1.11 per Firm Share, less underwriting
discounts and commissions, pursuant to an effective registration statement on Form S-3 (File No. 333-232402) and a related
prospectus supplement filed with the Securities and Exchange Commission. Under the terms of the Underwriting Agreement, the Company
also granted the Underwriter an option exercisable for 30 days to purchase up to an additional 546,000 shares (the &#8220;Additional
Shares&#8221; and together with the Firm Shares, the &#8220;Public Securities&#8221;) from the Company at the Firm Share price, less
underwriting discounts and commissions, to cover over-allotments. The Underwriter exercised the over-allotment option in full on May 27, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company expects the net
proceeds from the Offering to be approximately $4.2 million after deducting underwriting discounts and commissions and estimated offering
expenses. The Company intends to use the net proceeds from the Offering for working capital, research and development, marketing and sales,
and general corporate purposes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Underwriting
Agreement contains customary representations, warranties and agreements by the Company, customary conditions to closing,
indemnification obligations of the Company and the Underwriter, including for liabilities under the Securities Act of 1933, as
amended, various other obligations of the parties, and termination provisions. In addition, under the Underwriting Agreement, the
Company agreed, subject to certain exceptions, not to offer, pledge, sell, contract to sell, sell any option, right or warrant to
purchase, lend or otherwise transfer or dispose, directly or indirectly, any shares of the Company&#8217;s common stock or any
securities convertible into or exercisable or exchangeable for shares of common stock, for a period of 90 days from the date of the
Underwriting Agreement, without the prior written consent of the Underwriter; provided, however, that the Company may sell shares of
common stock under its At-The-Market offering program with Virtu Americas LLC following such date that is 30 days from the date of
the Underwriting Agreement. The Offering is expected to close on or about June 1, 2022, subject to the closing conditions contained
in the Underwriting Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The above description of the
Underwriting Agreement is qualified in its entirety by reference to the full text of the Underwriting Agreement, a copy of which is filed
as Exhibit 1.1 hereto and is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Mitchell
Silberberg &amp; Knupp LLP, counsel to the Company, has issued an opinion to the Company, dated May 31, 2022, regarding the validity of
the Public Securities. A copy of the opinion is filed as Exhibit 5.1 to this Current Report on Form 8-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Waiver from clirSPV LLC of its Purchase Right</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with a private placement of the Company&#8217;s
common stock, pursuant to a Stock Purchase Agreement dated July 12, 2018, we granted to clirSPV LLC a right to purchase certain new equity
securities that we sell for the purpose of raising capital on terms and conditions no different from those offered to other purchasers
(the &#8220;Purchase Right&#8221;). In no event, however, may this Purchase Right be exercised to the extent it would cause clirSPV LLC
to own 20% or more of the Company&#8217;s then outstanding shares of common stock or hold shares with 20% or more of the voting power
of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Because certain elements of this Purchase Right,
such as the notice provisions and closing period, are not compatible with raising capital in a public offering, on May 26, 2022, clirSPV
LLC agreed to waive the notice requirements and other related closing mechanics for such Purchase Right (the &#8220;Waiver&#8221;). In
exchange for such Waiver, we and clirSPV LLC agreed that, following the initial closing of the Offering, clirSPV LLC may purchase from
us, at the price sold to the investors in the Offering, unregistered shares of our common stock in a number that will allow it to maintain
a 19.99% percentage ownership of our outstanding common stock, provided that clirSPV LLC notifies us that it will exercise such right
within 30 days following the final closing of the Offering and the completion of such purchase must occur within six (6) business days
of the final closing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, the Company and clirSPV LLC have agreed
that effective upon the Investor Holder Consent (as defined below), the Purchase Right, subject to the Waiver and modification contained
therein, will be extended from December 31, 2023 to such date that the holders of two-thirds of the outstanding units of clirSPV LLC agree
(the &#8220;Investor Holder Consent&#8221;) to extend such holder&#8217;s existing agreement that he/she/it will have no right to force
a redemption of his/her/its interests in clirSPV LLC; provided, however, that clirSPV LLC provides written notice to the Company of the
Investor Holder Consent prior to December 31, 2023 and the Purchase Right will in no event extend beyond June 30, 2027.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Robert T. Hoffman Sr., a member of our board of
directors, is the managing member of GPclirSPV LLC, which is the managing member of clirSPV LLC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The above description of the
Waiver is qualified in its entirety by reference to the full text of the Waiver, a copy of which is filed as Exhibit 10.1 hereto and is
incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>Item 8.01 Other Events. </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">On
May 26</span>, 2022, the Company issued a press release announcing that it had launched the Offering and on May 27, 2022, the Company
issued a press release announcing that it had priced the Offering. The press releases are filed as Exhibits 99.1 and 99.2 to this Current
Report and are incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>Item 9.01 Financial
Statements and Exhibits. </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Exhibits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 5%">&#160;</td>
    <td style="width: 10%; text-align: left"><a href="tm2217097d1_ex1-1.htm">1.1</a></td>
    <td style="width: 85%; text-align: justify"><a href="tm2217097d1_ex1-1.htm">Underwriting Agreement, dated as of May 27, 2022, between the Company and Newbridge Securities Corporation</a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: left"><a href="tm2217097d1_ex5-1.htm">5.1</a></td>
    <td style="text-align: justify"><a href="tm2217097d1_ex5-1.htm">Legal opinion of Mitchell Silberberg &amp; Knupp LLP</a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: left"><a href="tm2217097d1_ex10-1.htm" style="-sec-extract: exhibit">10.1</a></td>
    <td style="text-align: justify"><a href="tm2217097d1_ex10-1.htm" style="-sec-extract: exhibit">Purchase Right Waiver of clirSPV LLC</a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: left"><a href="tm2217097d1_ex5-1.htm">23.1</a></td>
    <td style="text-align: justify"><a href="tm2217097d1_ex5-1.htm">Consent of Mitchell Silberberg &amp; Knupp LLP (included in exhibit 5.1)</a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: left"><a href="tm2217097d1_ex99-1.htm">99.1</a></td>
    <td style="text-align: justify"><a href="tm2217097d1_ex99-1.htm">Press release issued May <span style="font-family: Times New Roman, Times, Serif">26</span>, 2022</a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: left"><a href="tm2217097d1_ex99-2.htm">99.2</a></td>
    <td style="text-align: justify"><a href="tm2217097d1_ex99-2.htm">Press release issued May <span style="font-family: Times New Roman, Times, Serif">27</span>, 2022</a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: left">104</td>
    <td style="text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Cover Page Interactive Data File (the cover page XBRL tags are embedded
within the inline XBRL document)</p></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><b>SIGNATURE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this Current Report to be signed on its behalf by the undersigned
hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">Dated:
May 31</span>, 2022</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2" style="text-align: left">CLEARSIGN TECHNOLOGIES
CORPORATION</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 50%">&#160;</td>
    <td style="text-align: left; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid; width: 47%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Colin James Deller</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Colin James Deller</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <!-- Field: /Page -->





</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFj0tqwzAQhk/gOwxah8QSaRfetaYNJU4JbijdKvakiFgaM1LS5ki9ZSdyQ8WAEP/j0yg1Uyt6dgMyfDy2DezQj4NNCC0ekDF0KI76ZV2B3C1+upjYhpSft2BNkkHJ3M11uRchW88uYl+B1guzXBgN5X2lDWw3qrjqNYWD6zEkZwewoYct08gOk+XL1LCz3xTIXzLqHTk6ClI3Lyf5B0wpfa90tl/ExwhNU6tilk+hVkyn8Yo5xUQengb0wopT9H/yV7rsqWQLT+EtUXfcoN8ji6RLI5SHP+TkgGy5FfwCSatb8Q== -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>tm2217097d1_ex1-1.htm
<DESCRIPTION>EXHIBIT 1.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 1.1</B></P>

<P STYLE="margin: 0; text-align: left"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNDERWRITING AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>between</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CLEARSIGN TECHNOLOGIES CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>and</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase"><B>NEWBRIDGE
SECURITIES CORPORATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">May 27, 2022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Newbridge Securities Corporation</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1200 North Federal Highway</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Boca Raton, Florida 33432</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned, ClearSign
Technologies Corporation, a corporation formed under the laws of the State of Washington (the &ldquo;<B>Company</B>&rdquo;), hereby confirms
its agreement (this &ldquo;<B>Agreement</B>&rdquo;) with Newbridge Securities Corporation (hereinafter referred to as &ldquo;<B>you</B>&rdquo;
or the &ldquo;<B>Underwriter</B>&rdquo;) as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-weight: normal">1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-weight: normal"><U>Purchase and Sale of Shares</U>.</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">1.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Firm Shares</U>.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-weight: normal">1.1.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Nature and Purchase of Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On the basis of the representations and warranties herein contained, but subject to the terms and conditions herein set forth, the Company
agrees to issue and sell to the Underwriter an aggregate of 3,640,000 shares (the &ldquo;</FONT><FONT STYLE="font-size: 10pt">Firm
Shares<FONT STYLE="font-weight: normal">&rdquo;) of commons stock, par value $0.0001 per share (&ldquo;</FONT>Common Stock<FONT STYLE="font-weight: normal">&rdquo;).</FONT></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Underwriter agrees to purchase from the Company the Firm Shares at a purchase price of $1.0434 per Firm Share (94% of the per Share
offering price). The Firm Shares are to be offered to the public at the offering price set forth on the cover page of the Prospectus (as
defined in <U>Section 2.1.1</U>).</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-weight: normal">1.1.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Firm Shares Payment and Delivery.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Delivery and payment for the Firm Shares shall be made at 10:00 a.m., Eastern time, on June 1, 2022 or at such earlier time as shall be
agreed upon by the Underwriter and the Company, at the offices of McGuireWoods LLP, 1251 Avenue of the Americas, 20<SUP>th</SUP> Floor,
New York, New York 10020 (&ldquo;</FONT><FONT STYLE="font-size: 10pt">Underwriter&rsquo;s Counsel<FONT STYLE="font-weight: normal">&rdquo;),
or at such other place (or remotely by electronic transmission) as shall be agreed upon by the Underwriter and the Company. The hour and
date of delivery and payment for the Firm Shares is called the &ldquo;</FONT>Closing Date<FONT STYLE="font-weight: normal">.&rdquo;</FONT></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payment for the Firm Shares shall be made on the Closing Date by wire transfer in Federal (same day) funds, payable to the order of the
Company upon delivery of the certificates (in form and substance satisfactory to the Underwriter) representing the Firm Shares (or through
the facilities of The Depository Trust Company (&ldquo;</FONT></FONT><FONT STYLE="font-size: 10pt">DTC<FONT STYLE="font-weight: normal">&rdquo;))
for the account of the Underwriter. The Firm Shares shall be registered in such name or names and in such authorized denominations as
the Underwriter may request in writing at least two (2) Business Days prior to the Closing Date. The Company shall not be obligated to
sell or deliver the Firm Shares except upon tender of payment by the Underwriter for all of the Firm Shares. The term &ldquo;</FONT>Business
Day<FONT STYLE="font-weight: normal">&rdquo; means any day other than a Saturday, a Sunday or a legal holiday or a day on which banking
institutions are authorized or obligated by law to close in New York, New York.</FONT></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">1.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Over-allotment Option</U>.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">1.2.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Additional
Shares.</U> The Company hereby grants to the Underwriter an option (the &ldquo;</FONT>Over-allotment Option<FONT STYLE="font-weight: normal">&rdquo;)
to purchase up to an additional 546,000 shares of Common Stock, representing up to 15% of the Firm Shares sold in the Offering (the &ldquo;</FONT>Additional
Shares<FONT STYLE="font-weight: normal">&rdquo;), for the purpose of covering over-allotments of such securities, if any. The Firm Shares
and the Additional Shares are collectively referred to as the &ldquo;</FONT>Public Securities<FONT STYLE="font-weight: normal">&rdquo;.
The Public Securities shall be issued directly by the Company and shall have the rights and privileges described in the Registration
Statement, the Disclosure Package and the Prospectus referred to below. The offering and sale of the Public Securities is herein referred
to as the &ldquo;</FONT>Offering<FONT STYLE="font-weight: normal">&rdquo;.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">1.2.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Exercise of the Option</U>. The Over-allotment Option granted pursuant to <U>Section 1.2.1</U> may be exercised by the Underwriter
as to all (at any time) or any part (from time to time) of the Additional Shares within 30 days after the date hereof. The purchase price
to be paid per Additional Share shall be equal to the price per Firm Share set forth in <U>Section 1.1.1</U>. The Underwriter shall not
be under any obligation to purchase any Additional Shares prior to the exercise of the Over-allotment Option. The Over-allotment Option
granted hereby shall be exercised by the giving of electronic notice to the Company from the Underwriter, which shall be confirmed in
writing by overnight mail or facsimile or other electronic transmission, setting forth the number of Additional Shares to be purchased
and the date and time for delivery of and payment for the Additional Shares (the &ldquo;</FONT>Option Closing Date<FONT STYLE="font-weight: normal">&rdquo;),
which shall not be later than five (5) full Business Days after the date of the notice or such other time as shall be agreed upon by the
Company and the Underwriter, at the offices of Underwriter&rsquo;s Counsel or at such other place (including remotely by electronic transmission)
as shall be agreed upon by the Company and the Underwriter. If such delivery and payment for the Additional Shares does not occur on the
Closing Date, the Option Closing Date will be as set forth in the notice. Upon exercise of the Over-allotment Option with respect to all
or any portion of the Additional Shares, subject to the terms and conditions set forth herein, the Company shall become obligated to sell
to the Underwriter the number of Additional Shares specified in such notice.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">1.2.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Payment and Delivery</U>. Payment for the Additional Shares shall be made on the Option Closing Date by wire transfer in Federal (same
day) funds, payable to the order of the Company upon delivery to you of certificates (in form and substance satisfactory to the Underwriter)
representing the Additional Shares (or through the facilities of DTC) for the account of the Underwriter. The Additional Shares shall
be registered in such name or names and in such authorized denominations as the Underwriter may request in writing at least two (2) Business
Days prior to the Option Closing Date. The Company shall not be obligated to sell or deliver the Additional Shares except upon tender
of payment by the Underwriter for applicable Additional Shares. The Option Closing Date may be simultaneous with, but not earlier than,
the Closing Date; and in the event that such time and date are simultaneous with the Closing Date, the term &ldquo;Closing Date&rdquo;
shall refer to the time and date of delivery of the Firm Shares and Additional Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-weight: normal">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Representations and Warranties of the Company</U>. The Company represents and warrants to the Underwriter as of the Applicable Time
(as defined below), as of the Closing Date and as of each Option Closing Date, if any, as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">2.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Filing of Registration Statement</U></FONT><FONT STYLE="font-weight: normal">.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">2.1.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company has filed with the U.S. Securities and Exchange Commission (the &ldquo;</FONT>Commission<FONT STYLE="font-weight: normal">&rdquo;)
a &ldquo;shelf&rdquo; registration statement on Form S-3 (File No. 333-232402) which became effective on July 12, 2019 (the &ldquo;</FONT>Effective
Date<FONT STYLE="font-weight: normal">&rdquo;), including a base prospectus dated July 12, 2019 relating to the securities registered
pursuant to such registration statement, for the registration under the Securities Act of 1933, as amended (the &ldquo;</FONT>Securities
Act<FONT STYLE="font-weight: normal">&rdquo;), of the offering and sale of up to $50 million worth of the Company&rsquo;s securities (including
common stock, preferred stock, debt securities, warrants, units and rights), which registration statement was prepared by the Company
in all material respects in conformity with the requirements of the Securities Act and the rules and regulations of the Commission under
the Securities Act (the &ldquo;</FONT>Securities Act Regulations<FONT STYLE="font-weight: normal">&rdquo;) and contains or will contain
all material statements that are required to be stated therein in accordance with the Securities Act and the Securities Act Regulations.
Except as the context may otherwise require, such registration statement on file with the Commission at any given time, including any
amendments thereto to such time, exhibits and schedules thereto at such time, documents filed as a part thereof or incorporated pursuant
to Item 12 of Form S-3 under the Securities Act at such time and the documents and information otherwise deemed to be a part thereof or
included therein pursuant to Rule 430B of the Securities Act Regulations (the &ldquo;</FONT>Rule 430B Information<FONT STYLE="font-weight: normal">&rdquo;)
or otherwise pursuant to the Securities Act Regulations at such time, is referred to herein as the &ldquo;</FONT>Registration Statement<FONT STYLE="font-weight: normal">.&rdquo;
The Registration Statement at the time it originally became effective is referred to herein as the &ldquo;</FONT>Initial Registration
Statement<FONT STYLE="font-weight: normal">.&rdquo; If the Company files any registration statement pursuant to Rule 462(b) of the Securities
Act Regulations, then after such filing, the term &ldquo;Registration Statement&rdquo; shall include such registration statement filed
pursuant to Rule 462(b). The Registration Statement was declared effective by the Commission on July 12, 2019. An aggregate amount of
approximately $29,825,000 of securities remain available for sale under the Registration Statement and the Company meets the transaction
requirements with respect to the aggregate market value of securities being sold pursuant to this Offering and during the twelve (12)
calendar months prior to this offering, as set forth in General Instruction I.B.6 of Form S-3.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">The prospectus in the form in
which it was filed with the Commission in connection with the Initial Registration Statement is herein called the &ldquo;<B>Base Prospectus</B>.&rdquo;
Each preliminary prospectus supplement to the Base Prospectus (including the Base Prospectus as so supplemented) that described the Public
Securities and the Offering and omitted the Rule 430B Information and that was used prior to the filing of the final prospectus supplement
referred to in the following paragraph is herein called a &ldquo;<B>Preliminary Prospectus</B>.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">Promptly after the execution
and delivery of this Agreement, the Company will prepare and file with the Commission a final prospectus supplement to the Base Prospectus
relating to the Public Securities and the Offering in accordance with the provisions of Rule 430B and Rule 424(b) of the Securities Act
Regulations. Such final prospectus supplement (including the Base Prospectus as so supplemented), in the form filed with the Commission
pursuant to Rule 424(b) under the Securities Act is herein called the &ldquo;<B>Prospectus</B>.&rdquo; Any reference herein to the Base
Prospectus, any Preliminary Prospectus or the Prospectus shall be deemed to refer to and include the documents incorporated by reference
therein pursuant to Item 12 of Form S-3 under the Securities Act as of the date of such prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B>Applicable Time</B>&rdquo;
means 7:00 a.m., Eastern time, on the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B>Disclosure Package</B>&rdquo;
means any Issuer General Use Free Writing Prospectus issued at or prior to the Applicable Time, the Preliminary Prospectus dated May 26,
2022 and the information included on <U>Schedule 2-A</U> hereto, all considered together.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B>Issuer Free Writing
Prospectus</B>&rdquo; means any &ldquo;issuer free writing prospectus,&rdquo; as defined in Rule 433 of the Securities Act Regulations
(&ldquo;<B>Rule 433</B>&rdquo;), including without limitation any &ldquo;free writing prospectus&rdquo; (as defined in Rule 405 of the
Securities Act Regulations) relating to the Securities that is (i) required to be filed with the Commission by the Company, (ii) a &ldquo;road
show that is a written communication&rdquo; within the meaning of Rule 433(d)(8)(i), whether or not required to be filed with the Commission,
or (iii) exempt from filing with the Commission pursuant to Rule 433(d)(5)(i) because it contains a description of the Public Securities
or of the Offering that does not reflect the final terms, in each case in the form filed or required to be filed with the Commission or,
if not required to be filed, in the form retained in the Company&rsquo;s records pursuant to Rule 433(g).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B>Issuer General Use
Free Writing Prospectus</B>&rdquo; means any Issuer Free Writing Prospectus that is intended for general distribution to prospective investors
(other than a &ldquo;<I>bona fide</I> electronic road show,&rdquo; as defined in Rule 433 (the &ldquo;<B>Bona Fide Electronic Road Show</B>&rdquo;)),
as evidenced by its being specified in <U>Schedule 1-B</U> hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B>Issuer Limited Use
Free Writing Prospectus</B>&rdquo; means any Issuer Free Writing Prospectus that is not an Issuer General Use Free Writing Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">2.1.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Pursuant to the Exchange Act.</U> The Common Stock is registered pursuant to Section 12(b) under the Securities Exchange Act of 1934,
as amended (the &ldquo;</FONT>Exchange Act<FONT STYLE="font-weight: normal">&rdquo;). The Company has taken no action designed to, or
likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act, nor has the Company received any
notification that the Commission is contemplating terminating such registration.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">2.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Stock Exchange Listing.</U> The Common Stock is listed on The Nasdaq Capital Market (the &ldquo;</FONT><FONT STYLE="font-style: normal">NasdaqCM<FONT STYLE="font-weight: normal">&rdquo;),
and the Company has taken no action designed to, or likely to have the effect of, delisting the Common Stock from the NasdaqCM, nor has
the Company received any notification that the NasdaqCM is contemplating terminating such listing, except as described in the Registration
Statement, the Disclosure Package and the Prospectus.</FONT></FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">2.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No Stop Orders, etc</U>. Neither the Commission nor any state regulatory authority has issued any order preventing or suspending the
use of the Registration Statement, any Preliminary Prospectus or the Prospectus or has instituted or, to the Company&rsquo;s knowledge,
threatened to institute, any proceedings with respect to such an order. The Company has complied with each request (if any) from the Commission
for additional information.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">2.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Disclosures in Registration Statement</U>.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">2.4.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Compliance with Securities Act and 10b-5 Representation</U>. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-weight: normal">(i)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each of the Registration Statement and any post-effective amendment thereto, at the time it became effective (including each deemed effective
date with respect to the Underwriter pursuant to Rule 430B or otherwise under the Securities Act) complied in all material respects with
the requirements of the Securities Act and the Securities Act Regulations. The conditions for use of Form S-3 set forth in the General
Instructions thereto, including but not limited to, General Instruction I.B.6 and other conditions related to the offer and sale of the
Securities have been satisfied. Each Preliminary Prospectus, including the prospectus filed as part of the Registration Statement as originally
filed or as part of any amendment or supplement thereto, and the Prospectus, at the time each was filed or will be filed with the Commission,
at the date of this Agreement and at the Closing Date and each Option Closing Date, complied or will comply in all material respects with
the requirements of the Securities Act and the Securities Act Regulations. Each Preliminary Prospectus delivered to the Underwriter for
use in connection with this Offering and the Prospectus was or will be identical to the electronically transmitted copies thereof filed
with the Commission pursuant to EDGAR, except to the extent permitted by Regulation S-T.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-weight: normal">(ii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither the Registration Statement nor any amendment thereto, at its Effective Date, as of the Applicable Time, or at the Closing Date
or at any Option Closing Date contained, contains or will contain an untrue statement of a material fact or omitted, omits or will omit
to state a material fact required to be stated therein or necessary to make the statements therein not misleading.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-weight: normal">(iii)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Disclosure Package, as of the Applicable Time, as of the date of this Agreement, at the Closing Date or any Option Closing Date did
not, does not and will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make
the statements therein, in the light of the circumstances under which they were made, not misleading; and each Issuer Limited Use Free
Writing Prospectus hereto does not conflict with the information contained in the Registration Statement, the Preliminary Prospectus or
the Prospectus, and each such Issuer Limited Use Free Writing Prospectus, as supplemented by and taken together with the Prospectus as
of the Applicable Time, did not include an untrue statement of a material fact or omit to state a material fact necessary in order to
make the statements therein, in the light of the circumstances under which they were made, not misleading; <I><U>provided</U></I>, <I><U>however</U></I>,
that this representation and warranty shall not apply to statements made or statements omitted in reliance upon and in conformity with
written information furnished to the Company with respect to the Underwriter by the Underwriter expressly for use in the Registration
Statement, the Disclosure Package or the Prospectus or any amendment thereof or supplement thereto. The parties acknowledge and agree
that such information provided by or on behalf of the Underwriter consists solely of the following disclosure contained in the &ldquo;Underwriting&rdquo;
section of the Prospectus: (i) the table showing the number of securities to be purchased by the Underwriter, (ii) the third full paragraph
and (iii) the sub-sections titled &ldquo;Additional Relationships,&rdquo; &ldquo;Electronic Prospectus&rdquo; and &ldquo;Stabilization&rdquo;
(collectively, the &ldquo;</FONT></FONT><FONT STYLE="font-size: 10pt">Underwriter&rsquo;s Information<FONT STYLE="font-weight: normal">&rdquo;);
and</FONT></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-weight: normal">(iv)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neither the Prospectus nor any amendment or supplement thereto (including any prospectus wrapper), as of its issue date, at the time of
any filing with the Commission pursuant to Rule 424(b) or at the Closing Date or any Option Closing Date, included, includes or will include
an untrue statement of a material fact or omitted, omits or will omit to state a material fact necessary in order to make the statements
therein, in the light of the circumstances under which they were made, not misleading; <I>provided</I>, <I>however</I>, that this representation
and warranty shall not apply to the&nbsp;Underwriter&rsquo;s Information.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">2.4.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Disclosure of Agreements</U>. The agreements and documents described in the Registration Statement, the Disclosure Package and the
Prospectus conform in all material respects to the descriptions thereof contained therein, and there are no agreements or other documents
required by the Securities Act, the Securities Act Regulations or the Exchange Act to be described in the Registration Statement, the
Disclosure Package and the Prospectus or to be filed with the Commission as exhibits to the Registration Statement, that have not been
so filed. Each agreement or other instrument (however characterized or described) to which the Company or the Subsidiary is a party or
by which it is or may be bound or affected and (i)&nbsp;that is referred to or incorporated by reference in the Registration Statement,
the Disclosure Package and the Prospectus, or (ii)&nbsp;is material to the Company&rsquo;s business, has been duly authorized and validly
executed by the Company, is in full force and effect in all material respects and is enforceable against the Company and, to the Company&rsquo;s
knowledge, the other parties thereto, in accordance with its terms, except (x)&nbsp;as such enforceability may be limited by bankruptcy,
insolvency, reorganization or similar laws affecting creditors&rsquo; rights generally, (y)&nbsp;as enforceability of any indemnification
or contribution provision may be limited under the federal and state securities laws, and (z)&nbsp;that the remedy of specific performance
and injunctive and other forms of equitable relief may be subject to the equitable defenses and to the discretion of the court before
which any proceeding therefor may be brought. None of such agreements or instruments has been assigned by the Company, and neither the
Company nor, to the Company&rsquo;s knowledge, any other party is in default thereunder and, to the Company&rsquo;s knowledge, no event
has occurred that, with the lapse of time or the giving of notice, or both, would constitute a default thereunder. Performance by the
Company of the material provisions of such agreements or instruments will not result in a material violation of any existing applicable
law, rule, regulation, judgment, order or decree of any governmental or regulatory agency, body or court, domestic or foreign, having
jurisdiction over the Company or any of its assets or business (each, a &ldquo;</FONT>Governmental Entity<FONT STYLE="font-weight: normal">&rdquo;),
including, without limitation, those relating to environmental laws and regulations.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">2.4.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Prior Securities Transactions</U>. Since January 1, 2020, no securities of the Company have been sold by the Company or by or on behalf
of, or for the benefit of, any person or persons controlling, controlled by or under common control with the Company, except as disclosed
in the Registration Statement, the Disclosure Package and the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">2.4.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Regulations</U>. The disclosures in the Registration Statement, the Disclosure Package and the Prospectus concerning the effects of
federal, state, local and all foreign laws, rules and regulations relating to the Company&rsquo;s business as currently conducted or contemplated
to be conducted are correct and complete in all material respects and no other such laws, rules or regulations are required to be disclosed
in the Registration Statement, the Disclosure Package and the Prospectus that are not so disclosed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">2.4.5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Other Distribution of Offering Materials.</U> The Company has not, directly or indirectly, distributed and will not distribute any offering
material in connection with the Offering other than any Preliminary Prospectus, the Disclosure Package, the Prospectus and other materials,
if any, permitted under the Securities Act and consistent with <U>Section 3.2</U> below. The Company is not an &ldquo;ineligible issuer&rdquo;
in connection with the Offering pursuant to Rules 164, 405 and 433 under the Securities Act. The Company will file with the Commission
all Issuer Free Writing Prospectuses (other than a &ldquo;road show&rdquo; as defined in Rule 433(d) of the Securities Act Regulations,
if any) in the time and manner required under Rule 433(d) of the Securities Act Regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">2.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Changes After Dates in Registration Statement</U>.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">2.5.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No Material Adverse Change</U>. Since the respective dates as of which information is given in the Registration Statement, the Disclosure
Package and the Prospectus, except as otherwise specifically stated therein: (i)&nbsp;there has been no material adverse change in the
condition (financial or otherwise), results of operations, business, assets, properties or prospects of the Company and the Subsidiary,
taken as a whole (a &ldquo;</FONT>Material Adverse Change<FONT STYLE="font-weight: normal">&rdquo;); (ii)&nbsp;there have been no material
transactions entered into by the Company, other than as contemplated pursuant to this Agreement; and (iii)&nbsp;no officer or director
of the Company or the Subsidiary has resigned from any position with the Company or the Subsidiary.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">2.5.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>&nbsp;Recent
Securities Transactions, etc.</U> Subsequent to the respective dates as of which information is given in the Registration Statement,
the Disclosure Package and the Prospectus, and except as may otherwise be indicated or contemplated herein or disclosed in the Registration
Statement, the Disclosure Package and the Prospectus, the Company has not: (i)&nbsp;issued any securities or incurred any liability or
obligation, direct or contingent, for borrowed money; or (ii)&nbsp;declared or paid any dividend or made any other distribution on or
in respect to its capital stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">2.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Disclosures in Commission Filings</U>. Since January 1, 2019, (i) none of the Company&rsquo;s filings with the Commission contained
any untrue statement of a material fact or omitted to state any material fact necessary in order to make the statements therein, in light
of the circumstances under which they were made, not misleading; and (ii) the Company has made all filings with the Commission required
under the Exchange Act and the rules and regulations of the Commission promulgated thereunder (the &ldquo;</FONT><FONT STYLE="font-style: normal">Exchange
Act Regulations<FONT STYLE="font-weight: normal">&rdquo;).</FONT></FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">2.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Independent Accountants</U>. To the Company&rsquo;s knowledge, BPM LLP (the &ldquo;</FONT><FONT STYLE="font-style: normal">Current
Auditor<FONT STYLE="font-weight: normal">&rdquo;), whose report is filed with the Commission as part of the Registration Statement, the
Disclosure Package and the Prospectus, is an independent registered public accounting firm as required by the Securities Act and the Securities
Act Regulations and the Public Company Accounting Oversight Board. The Auditor has not, during the periods covered by the financial statements
included or incorporated by reference in the Registration Statement, the Disclosure Package and the Prospectus, provided to the Company
any prohibited non-audit services, as such term is used in Section 10A(g) of the Exchange Act. To the Company&rsquo;s knowledge, Gumbiner
Savett Inc. (the &ldquo;</FONT>Prior Auditor<FONT STYLE="font-weight: normal">&rdquo;), whose report is filed with the Commission as part
of the Registration Statement, the Disclosure Package and the Prospectus, was an independent registered public accounting firm as required
by the Securities Act and the Securities Act Regulations and the Public Company Accounting Oversight Board at all times during which it
audited the Company&rsquo;s financial statements. The Prior Auditor has not, during the periods covered by the financial statements included
or incorporated by reference in the Registration Statement, the Disclosure Package and the Prospectus, provided to the Company any prohibited
non-audit services, as such term is used in Section 10A(g) of the Exchange Act.</FONT></FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">2.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Financial Statements, etc</U>. The financial statements, including the notes thereto and supporting schedules, included or incorporated
by reference in the Registration Statement, the Disclosure Package and the Prospectus, fairly present the financial position and the results
of operations of the Company at the dates and for the periods to which they apply; and such financial statements have been prepared in
conformity with U.S. generally accepted accounting principles (&ldquo;</FONT><FONT STYLE="font-style: normal">GAAP<FONT STYLE="font-weight: normal">&rdquo;),
consistently applied throughout the periods involved (provided that unaudited interim financial statements are subject to year-end audit
adjustments that are not expected to be material in the aggregate and do not contain all footnotes required by GAAP); and the supporting
schedules, if any, included in the Registration Statement, the Disclosure Package and the Prospectus present fairly the information required
to be stated therein. Except as included therein, no historical or pro forma financial statements are required to be included or incorporated
by reference in the Registration Statement, the Disclosure Package or the Prospectus under the Securities Act or the Securities Act Regulations.
All disclosures contained in the Registration Statement, the Disclosure Package or the Prospectus regarding &ldquo;non-GAAP financial
measures&rdquo; (as such term is defined by the rules and regulations of the Commission), if any, comply with Regulation G of the Exchange
Act and Item 10 of Regulation S-K of the Securities Act, to the extent applicable. Each of the Registration Statement, the Disclosure
Package and the Prospectus discloses all material off-balance sheet transactions, arrangements, obligations (including contingent obligations),
and other relationships of the Company with unconsolidated entities or other persons that may have a material current or future effect
on the Company&rsquo;s financial condition, changes in financial condition, results of operations, liquidity, capital expenditures, capital
resources, or significant components of revenues or expenses. Except as disclosed or incorporated by reference in the Registration Statement,
the Disclosure Package and the Prospectus, (a) the Company has not incurred any material liabilities or obligations, direct or contingent,
or entered into any material transactions other than in the ordinary course of business, (b) the Company has not declared or paid any
dividends or made any distribution of any kind with respect to its capital stock, (c) there has not been any change in the capital stock
of the Company, (d) other than in the ordinary course of business and consistent with the Company&rsquo;s prior policies, made any grants
under any stock compensation plan, and (e) there has not been any material adverse change in the Company&rsquo;s long-term or short-term
debt.</FONT></FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">2.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Authorized Capital; Options, etc</U>. The Company had, at the date or dates indicated in the Registration Statement, the Disclosure
Package and the Prospectus, the duly authorized, issued and outstanding capitalization as set forth therein. Based on the assumptions
stated in the Registration Statement, the Disclosure Package and the Prospectus, the Company will have on the Closing Date and each Option
Closing Date, if any, the adjusted stock capitalization set forth therein. Except as set forth in, or contemplated by, the Registration
Statement, the Disclosure Package, the Prospectus, on the Effective Date, as of the Applicable Time and on the Closing Date and any Option
Closing Date, there will be no stock options, warrants, or other rights to purchase or otherwise acquire any authorized, but unissued
shares of Common Stock or any security convertible or exercisable into shares of Common Stock, or any contracts or commitments to issue
or sell shares of Common Stock or any such options, warrants, rights or convertible securities.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">2.10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Valid Issuance of Securities, etc.</U></FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">2.10.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Outstanding Securities</U>. All issued and outstanding securities of the Company issued prior to the transactions contemplated by this
Agreement have been duly authorized and validly issued and are fully paid and non-assessable; the holders thereof have no rights of rescission
or the ability to force the Company to repurchase such securities with respect thereto, and are not subject to personal liability by reason
of being such holders; and none of such securities were issued in violation of the preemptive rights, rights of first refusal or rights
of participation of any holders of any security of the Company or similar contractual rights granted by the Company. The authorized shares
of Common Stock conform in all material respects to all statements relating thereto contained in the Registration Statement, the Disclosure
Package and the Prospectus. The offers and sales of the outstanding shares of Common Stock, options, warrants and other rights to purchase
or exchange such securities for shares of Common Stock were at all relevant times either registered under the Securities Act and the applicable
state securities or &ldquo;blue sky&rdquo; laws or, based in part on the representations and warranties of the purchasers of such shares
of Common Stock, exempt from such registration requirements. The description of the Company&rsquo;s stock option, stock bonus and other
stock plans or arrangements, and the options or other rights granted thereunder, as described in the Registration Statement, the Disclosure
Package and the Prospectus, accurately and fairly present, in all material respects, the information required to be shown with respect
to such plans, arrangements, options and rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">2.10.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Shares
Sold Pursuant to this Agreement.</U> The Public Securities have been duly authorized for issuance and sale and, when issued and paid
for, will be validly issued, fully paid and non-assessable; the holders thereof are not and will not be subject to personal liability
by reason of being such holders; the Public Securities are not and will not be subject to the preemptive rights of any holders of any
security of the Company or similar contractual rights granted by the Company, except with respect to which valid waivers have been obtained
prior to the date hereof; and all corporate action required to be taken for the authorization, issuance and sale of the Public Securities
has been duly and validly taken. The Public Securities conform in all material respects to all statements with respect thereto contained
in the Registration Statement, the Disclosure Package and the Prospectus. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">2.11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Registration Rights of Third Parties</U>. Except as set forth in the Registration Statement, the Disclosure Package and the Prospectus,
no holders of any securities of the Company or any options, warrants, rights or other securities exercisable for or convertible or exchangeable
into securities of the Company have the right to require the Company to register the sale or resale of any such securities of the Company
under the Securities Act or to include any such securities in the Registration Statement or any other registration statement to be filed
by the Company.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">2.12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Validity and Binding Effect of Agreement</U>. The execution, delivery and performance of this Agreement have been duly and validly
authorized by the Company, and, when executed and delivered, will constitute, the valid and binding agreement of the Company, enforceable
against the Company in accordance with its terms, except: (i)&nbsp;as such enforceability may be limited by bankruptcy, insolvency, reorganization
or similar laws affecting creditors&rsquo; rights generally; (ii)&nbsp;as enforceability of any indemnification or contribution provision
may be limited under the federal and state securities laws; and (iii)&nbsp;that the remedy of specific performance and injunctive and
other forms of equitable relief may be subject to the equitable defenses and to the discretion of the court before which any proceeding
therefor may be brought.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">2.13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No Conflicts, etc</U>. The execution, delivery and performance by the Company of this Agreement and all ancillary documents, the consummation
by the Company of the transactions herein and therein contemplated and the compliance by the Company with the terms hereof and thereof
do not and will not, with or without the giving of notice or the lapse of time or both: (i)&nbsp;result in a material breach of, or conflict
with any of the terms and provisions of, or constitute a material default under, or result in the creation, modification, termination
or imposition of any lien, charge or encumbrance upon any property or assets of the Company or the Subsidiary pursuant to the terms of
any indenture, mortgage, deed of trust, loan agreement or any other agreement or instrument to which the Company or the Subsidiary is
a party or as to which any property of the Company or the Subsidiary is a party; (ii)&nbsp;result in any violation of the provisions of
the Company&rsquo;s certificate of incorporation (as the same may be amended or restated from time to time, the &ldquo;</FONT><FONT STYLE="font-style: normal">Charter<FONT STYLE="font-weight: normal">&rdquo;)
or the Company&rsquo;s bylaws (as the same may be amended or restated from time to time, the &ldquo;</FONT>Bylaws<FONT STYLE="font-weight: normal">&rdquo;);
or (iii)&nbsp;violate any existing applicable law, rule, regulation, judgment, order or decree of any Governmental Entity as of the date
hereof, except in the case of <U>clause (i)</U> or <U>(iii), </U>as would not result in a Material Adverse Change.</FONT></FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">2.14&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No Defaults; Violations</U>. No material default exists, and no event has occurred that, with the lapse of time or the giving of notice,
or both, would constitute a default, in the due performance and observance of any term, covenant or condition of any material license,
contract, indenture, mortgage, deed of trust, note, loan or credit agreement, or any other agreement or instrument evidencing an obligation
for borrowed money, or any other material agreement or instrument to which the Company or the Subsidiary is a party or by which the Company
or the Subsidiary may be bound or to which any of the properties or assets of the Company or the Subsidiary is subject. Neither the Company
nor the Subsidiary is (i) in violation of any term or provision of its Charter or Bylaws, or (ii) in violation of any franchise, license,
permit, applicable law, rule, regulation, judgment or decree of any Governmental Entity, except in the case <U>clause (ii)</U>, such as
would not result in a Material Adverse Change.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">2.15&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Corporate Power; Licenses</U>.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">2.15.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Corporate Power</U>. The Company has all requisite corporate power and authority, as of the date hereof, the Applicable Time, the Closing
Date and any Option Closing Date, to conduct its business as described in the Registration Statement, the Disclosure Package and the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">2.15.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Licenses</U>. The Company (A) possesses the licenses, permits, certificates, authorizations, consents and approvals (collectively,
 &ldquo;</FONT>Authorizations<FONT STYLE="font-weight: normal">&rdquo;) issued by the appropriate governmental entities necessary to conduct
its business as currently conducted as described in the Registration Statement, the Disclosure Package and the Prospectus, and (B) has
obtained all necessary Authorizations from other persons necessary to conduct its business, except, in each case of <U>clauses (A)</U>
and <U>(B)</U>, (i) as described in the Registration Statement, the Disclosure Package or the Prospectus or (ii) to the extent that any
failure to possess any Authorizations, provide any notice, make any filing, or obtain any Governmental Licenses would not, individually
or in the aggregate, reasonably be expected to result in a Material Adverse Change; none of the Company and subsidiaries is in violation
of, or in default under, any Governmental License, except as those that would not reasonably be expected to result in a Material Adverse
Change. All of the Authorizations are valid and in full force and effect, except when the invalidity of such Authorizations or the failure
of such Authorizations to be in full force and effect would not, individually or in the aggregate, reasonably be expected to result in
a Material Adverse Change. The Company has not received any notice of proceedings relating to the revocation or modification of any Authorization
which, individually or in the aggregate, if the subject of an unfavorable decision, ruling or finding, would result in a Material Adverse
Change.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">2.15.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Transactions Contemplated Herein</U>. The Company has all corporate power and authority to enter into this Agreement and to carry out
the provisions and conditions hereof, and all Authorizations required in connection therewith have been obtained. No Authorization of,
and no filing with, any Governmental Entity is required for the valid issuance, sale and delivery of the Public Securities and the consummation
of the transactions and agreements contemplated by this Agreement and as contemplated by the Registration Statement, the Disclosure Package
and the Prospectus, except with respect to applicable federal and state securities laws and the rules and regulations of the Financial
Industry Regulatory Authority, Inc. (&ldquo;</FONT>FINRA<FONT STYLE="font-weight: normal">&rdquo;).</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">2.16&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>D&amp;O Questionnaires</U>. To the Company&rsquo;s knowledge, all information contained in the FINRA questionnaires (the &ldquo;</FONT><FONT STYLE="font-style: normal">Questionnaires<FONT STYLE="font-weight: normal">&rdquo;)
completed by each of the Company&rsquo;s directors, officers o and principal shareholders immediately prior to the Offering (the &ldquo;</FONT>Insiders<FONT STYLE="font-weight: normal">&rdquo;)
as supplemented by all information concerning the Company&rsquo;s directors, officers and principal shareholders as described in the Registration
Statement, the Disclosure Package and the Prospectus, as well as in the Lock-Up Agreement (as defined in <U>Section 2.26</U>), provided
to the Underwriter is true and correct in all material respects and the Company has not become aware of any information that would cause
the information disclosed in the Questionnaires to become inaccurate and incorrect in any material respect.</FONT></FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">2.17&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Litigation; Governmental Proceedings</U>. There is no action, suit, proceeding, inquiry, arbitration, investigation, litigation or
governmental proceeding pending or, to the Company&rsquo;s knowledge, threatened against, or involving the Company or the Subsidiary,
or to the Company&rsquo;s knowledge, any executive officer or director that has not been disclosed in the Registration Statement, the
Disclosure Package and the Prospectus or in connection with the Company&rsquo;s listing of the Public Securities on the NasdaqCM, which
if resolved adversely to the Company is reasonably likely to result in a Material Adverse Change or is required to be disclosed. </FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">2.18&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Good Standing</U>. Each of the Company and the Subsidiary has been duly organized and is validly existing as a corporation and is in
good standing under the laws of its jurisdiction of incorporation as of the date hereof, and is duly qualified to do business and is in
good standing in each other jurisdiction in which its ownership or lease of property or the conduct of business requires such qualification,
except where the failure to qualify, singularly or in the aggregate, would not have or reasonably be expected to result in a Material
Adverse Change.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">2.19&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Insurance</U>. Each of the Company and the Subsidiary carries or is entitled to the benefits of insurance (including, without limitation,
as to directors and officers insurance coverage) with reputable insurers, in such amounts and covering such risks which the Company reasonably
believes are adequate, and all such insurance is in full force and effect. The Company and the Subsidiary each have no reason to believe
that it will not be able (i) to renew its existing insurance coverage as and when such policies expire or (ii) to obtain comparable coverage
from similar institutions as may be necessary or appropriate to conduct its business as now conducted and at a cost that would not result
in a Material Adverse Change.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">2.20&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Transactions Affecting Disclosure to FINRA</U>.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">2.20.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Finder&rsquo;s Fees</U>. There are no claims, payments, arrangements, agreements or understandings relating to the payment of a finder&rsquo;s,
consulting or origination fee by the Company, the Subsidiary or any Insider with respect to the sale of the Public Securities hereunder
or any other arrangements, agreements or understandings of the Company or, to the Company&rsquo;s knowledge, any of its shareholders that
may affect the Underwriter&rsquo;s compensation, as determined by FINRA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">2.20.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Payments Within Twelve (12) Months</U>. Except as set forth in and pursuant to the &ldquo;At-the-Market&rdquo; Sales Agreement, dated
December 23, 2020 (the &ldquo;</FONT>ATM Sales Agreement<FONT STYLE="font-weight: normal">&rdquo;), by and between the Company and Virtu
Americas LLC, the Company has not made any direct or indirect payments (in cash, securities or otherwise) to: (i)&nbsp;any person, as
a finder&rsquo;s fee, consulting fee or otherwise, in consideration of such person raising capital for the Company or introducing to the
Company persons who raised or provided capital to the Company; (ii) any FINRA member; or (iii)&nbsp; any person or entity that has any
direct or indirect affiliation or association with any FINRA member, within the twelve (12) months prior to the Effective Date, other
than the payment to the Underwriter as provided hereunder in connection with the Offering.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">2.20.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Use of Proceeds</U>. None of the net proceeds of the Offering will be paid by the Company to any participating FINRA member or its
affiliates, except as specifically authorized herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">2.20.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>FINRA Affiliation</U>. There is no (i) officer or director of the Company, (ii) beneficial owner of 5% or more of any class of the
Company&rsquo;s securities or (iii) beneficial owner of the Company&rsquo;s unregistered equity securities which were acquired during
the 180-day period immediately preceding the filing of the Registration Statement that is an affiliate or associated person of a FINRA
member participating in the Offering (as determined in accordance with the rules and regulations of FINRA). Neither the Company nor any
of its affiliates (within the meaning of FINRA&rsquo;s Conduct Rule 5121(f)(i)) directly or indirectly controls, is controlled by, or
is under common control with, or is an associated person (within the meaning of Article 1, Section 1(ee) of the By-Laws of FINRA) or,
any member of FINRA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">2.20.5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Information</U>. All information provided by the Company in its FINRA questionnaire to Underwriter&rsquo;s Counsel specifically for
use by Underwriter&rsquo;s Counsel in connection with its Public Offering System filings (and related disclosure) with FINRA is true,
correct and complete in all material respects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">2.21&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Foreign Corrupt Practices Act</U>. Neither the Company, the Subsidiary nor, to the Company&rsquo;s knowledge, any director, officer,
agent, employee or affiliate of the Company, the Subsidiary nor any other person acting on behalf of the Company or the Subsidiary, has,
directly or indirectly, given or agreed to give any money, gift or similar benefit (other than legal price concessions to customers in
the ordinary course of business) to any customer, supplier, employee or agent of a customer or supplier, or official or employee of any
governmental agency or instrumentality of any government (domestic or foreign) or any political party or candidate for office (domestic
or foreign) or other person who was, is, or may be in a position to help or hinder the business of the Company or the Subsidiary (or assist
it in connection with any actual or proposed transaction) that (i)&nbsp;might subject the Company or the Subsidiary to any damage or penalty
in any civil, criminal or governmental litigation or proceeding, (ii)&nbsp;if not given in the past, might have had a Material Adverse
Change or (iii)&nbsp;if not continued in the future, might adversely affect the assets, business, operations or prospects of the Company
or the Subsidiary. Each of the Company and the Subsidiary has taken reasonable steps to ensure that its accounting controls and procedures
are sufficient to cause the Company and the Subsidiary to comply in all material respects with the Foreign Corrupt Practices Act of 1977,
as amended.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">2.22&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Compliance with OFAC</U>. Neither the Company, the Subsidiary nor, to the Company&rsquo;s knowledge, any director, officer, agent,
employee or affiliate of the Company, the Subsidiary nor any other person acting on behalf of the Company or the Subsidiary, is currently
subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Department of the Treasury (&ldquo;</FONT><FONT STYLE="font-style: normal">OFAC<FONT STYLE="font-weight: normal">&rdquo;),
and the Company will not, directly or indirectly, use the proceeds of the Offering hereunder, or lend, contribute or otherwise make available
such proceeds to any subsidiary, joint venture partner or other person or entity, for the purpose of financing the activities of any person
currently subject to any U.S. sanctions administered by OFAC.</FONT></FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">2.23&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Money Laundering Laws</U>. To the Company&rsquo;s knowledge after due inquiry, the operations of the Company and the Subsidiary are
and have been conducted at all times in compliance with applicable financial recordkeeping and reporting requirements of the Currency
and Foreign Transactions Reporting Act of 1970, as amended, the money laundering statutes of all jurisdictions, the rules and regulations
thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced by any Governmental Entity (collectively,
the &ldquo;</FONT><FONT STYLE="font-style: normal">Money Laundering Laws<FONT STYLE="font-weight: normal">&rdquo;); and no action, suit
or proceeding by or before any Governmental Entity involving the Company or the Subsidiary with respect to the Money Laundering Laws is
pending or, to the best knowledge of the Company, threatened.</FONT></FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">2.24&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Forward-Looking Statements</U>. No forward-looking statement (within the meaning of Section 27A of the Securities Act and Section 21E
of the Exchange Act) contained in either the Registration Statement, the Disclosure Package or the Prospectus has been made or reaffirmed
without a reasonable basis or has been disclosed other than in good faith.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">2.25&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Officers&rsquo; Certificate</U>. Any certificate signed by any duly authorized officer of the Company and delivered to you or to Underwriter&rsquo;s
Counsel shall be deemed a representation and warranty by the Company to the Underwriter as to the matters covered thereby.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">2.26&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Lock-Up Agreements. Schedule 2</U> hereto contains a complete and accurate list of the Company&rsquo;s executive officers and directors
as well as any stockholders deemed to be affiliates through their ownership of shares of the Company&rsquo;s Common Stock (collectively,
the &ldquo;</FONT><FONT STYLE="font-style: normal">Lock-Up Parties<FONT STYLE="font-weight: normal">&rdquo;). The Company has caused each
of the Lock-Up Parties to deliver to the Underwriter an executed Lock-Up Agreement, in the form attached hereto as <U>Exhibit A</U> (the
 &ldquo;</FONT>Lock-Up Agreement<FONT STYLE="font-weight: normal">&rdquo;), prior to the execution of this Agreement. </FONT></FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">2.27&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Subsidiary</U>. The Company owns 99.0% of the capital stock and/or the equity interests in ClearSign Asia Limited, a Hong Kong corporation
(the &ldquo;</FONT><FONT STYLE="font-style: normal">Subsidiary<FONT STYLE="font-weight: normal">&rdquo;). The Company has no other interest,
nominal or beneficial, direct or indirect, in any other corporation, partnership, limited liability company, joint venture or other business
entity. All of the outstanding shares of capital stock and/or equity interests of the Subsidiary have been duly authorized and validly
issued, are fully paid and non-assessable and, except to the extent set forth in the Registration Statement or the Prospectus, are owned
by the Company directly or indirectly through one or more wholly-owned subsidiaries, free and clear of any claim, lien, encumbrance, security
interest, restriction upon voting or transfer or any other claim of any third party. Except as disclosed in the Registration Statement
or the Prospectus, no director, officer, or key employee of the Company named in the Prospectus holds any direct equity, debt or other
pecuniary interest in the Subsidiary or, to the best of the Company&rsquo;s knowledge, any individual or entity with whom the Company
or the Subsidiary does business or with which it is in privity of contract.</FONT></FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">2.28&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Related Party Transactions</U>.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">2.28.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Business Relationships</U>. There are no business relationships or related party transactions involving the Company or the Subsidiary
or any other person required to be described in the Registration Statement, the Disclosure Package and the Prospectus that have not been
described as required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">2.28.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No Relationships with Customers and Suppliers</U>. No relationship, direct or indirect, exists between or among the Company or the
Subsidiary on the one hand, and the directors, officers, 5% or greater shareholders, customers or suppliers of the Company or the Subsidiary
or any of the Company&rsquo;s affiliates on the other hand, which is required to be described in the Registration Statement, the Disclosure
Package and the Prospectus or a document incorporated by reference therein and which is not so described.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">2.28.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No Unconsolidated Entities</U>. There are no transactions, arrangements or other relationships between and/or among the Company or
the Subsidiary, any of the Company&rsquo;s affiliates (as such term is defined in Rule 405 of the Securities Act) and any unconsolidated
entity, including, but not limited to, any structured finance, special purpose or limited purpose entity that could reasonably be expected
to materially affect the Company&rsquo;s liquidity or the availability of or requirements for its capital resources required to be described
in the Disclosure Package and the Prospectus or a document incorporated by reference therein which have not been described as required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">2.28.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No Loans or Advances to Affiliates</U>. There are no outstanding loans, advances (except normal advances for business expenses in the
ordinary course of business) or guarantees or indebtedness by the Company to or for the benefit of any of the officers or directors of
the Company or any of their respective family members, except as disclosed in the Registration Statement, the Disclosure Package and the
Prospectus. All transactions by the Company with its officers or directors or control persons of the Company have been duly approved by
the Board of Directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">2.29&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Board of Directors</U>. The Board of Directors of the Company is comprised of the persons set forth in the Company&rsquo;s proxy statement
on Schedule 14A filed with the Commission on April 22, 2022 and incorporated by reference into each Preliminary Prospectus and the Prospectus.
The qualifications of the persons serving as board members and the overall composition of the board comply with the Exchange Act, the
rules and regulations of the Commission under the Exchange Act Regulations, the Sarbanes-Oxley Act of 2002 and the rules promulgated thereunder
(the &ldquo;</FONT><FONT STYLE="font-style: normal">Sarbanes-Oxley Act<FONT STYLE="font-weight: normal">&rdquo;) applicable to the Company
and the listing rules of the NasdaqCM. At least one member of the Audit Committee of the Board of Directors of the Company qualifies as
an &ldquo;audit committee financial expert,&rdquo; as such term is defined under Regulation S-K and the listing rules of the NasdaqCM.
In addition, at least a majority of persons serving on the Board of Directors qualify as &ldquo;independent,&rdquo; as defined under the
listing rules of the NasdaqCM.</FONT></FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">2.30&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Sarbanes-Oxley Compliance</U>.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">2.30.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Disclosure Controls</U>. The Company has developed and currently maintains disclosure controls and procedures that comply with Rule
13a-15 or 15d-15 under the Exchange Act Regulations, and such controls and procedures are effective to ensure that information required
to be disclosed by the Company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported,
within the time periods specified in the Commission&rsquo;s rules and forms and includes, without limitation, controls and procedures
designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Exchange
Act is accumulated and communicated to the Company&rsquo;s management, including its principal executive and principal financial officers,
or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">2.30.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Compliance</U>. The Company is, or at the Applicable Time and on the Closing Date and each Option Closing Date, if any, will be, in
material compliance with the provisions of the Sarbanes-Oxley Act applicable to it, and has implemented or will implement such programs
and taken reasonable steps to ensure the Company&rsquo;s future compliance (not later than the relevant statutory and regulatory deadlines
therefor) with all of the material provisions of the Sarbanes-Oxley Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">2.31&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Accounting Controls</U>. The Company maintains systems of &ldquo;internal control over financial reporting&rdquo; (as defined under
Rules 13a-15 and 15d-15 under the Exchange Act Regulations) that comply with the requirements of the Exchange Act and have been designed
by, or under the supervision of, its principal executive and principal financial officer, or persons performing similar functions, to
provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting principles and includes those policies and procedures that: (1) pertain to the
maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the
Company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in
accordance with generally accepted accounting principles, and that receipts and expenditures of the issuer are being made only in accordance
with authorizations of management and directors of the Company; and (3) provide reasonable assurance regarding prevention or timely detection
of unauthorized acquisition, use or disposition of the Company&rsquo;s assets that could have a material effect on the financial statements.
Except as disclosed in the Registration Statement, the Disclosure Package and the Prospectus, the Company is not aware of any material
weaknesses in its internal controls. The Company&rsquo;s auditors and the Audit Committee of the Board of Directors of the Company have
been advised of: (i) all significant deficiencies and material weaknesses in the design or operation of internal controls over financial
reporting which are known to the Company&rsquo;s management and that have adversely affected or are reasonably likely to adversely affect
the Company&rsquo;s ability to record, process, summarize and report financial information; and (ii) any fraud known to the Company&rsquo;s
management, whether or not material, that involves management or other employees who have a significant role in the Company&rsquo;s internal
controls over financial reporting.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">2.32&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No Investment Company Status</U>. The Company is not and, after giving effect to the Offering and the application of the proceeds thereof
as described in the Registration Statement, the Disclosure Package and the Prospectus, will not be, required to register as an &ldquo;investment
company,&rdquo; as defined in the Investment Company Act of 1940, as amended.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">2.33&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No Labor Disputes</U>. No labor dispute with the employees of the Company or the Subsidiary exists or, to the knowledge of the Company
or the Subsidiary, is imminent. The Company is not aware that any key employee or significant group of employees of the Company or the
Subsidiary plans to terminate employment with the Company or the Subsidiary.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">2.34&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Intellectual Property Rights</U>. The Company owns or possesses or has valid rights to use all patents, patent applications, trademarks,
service marks, trade names, trademark registrations, service mark registrations, copyrights, licenses, inventions, trade secrets software,
databases, know-how, internet domain names, other unpatented and/or unpatentable proprietary confidential information systems, processes
or procedures and similar rights (&ldquo;</FONT><FONT STYLE="font-style: normal">Intellectual Property Rights<FONT STYLE="font-weight: normal">&rdquo;)
necessary for the conduct of the business of the Company and the Subsidiary as currently carried on and as described in the Registration
Statement, the Disclosure Package and the Prospectus. The Intellectual Property Rights licenses described in the Registration Statement,
Disclosure Package and the Prospectus are valid, binding upon and enforceable against the parties thereto in accordance with their respective
terms. To the knowledge of the Company, no action or use by the Company or the Subsidiary necessary for the conduct of its business as
currently carried on and as described in the Registration Statement, the Disclosure Package and the Prospectus will involve or give rise
to any infringement of, or license or similar fees for, any Intellectual Property Rights of others. Neither the Company nor the Subsidiary
has received any notice alleging any such infringement, fee or conflict with asserted Intellectual Property Rights of others. Except as
would not reasonably be expected to result, individually or in the aggregate, in a Material Adverse Change (A) to the knowledge of the
Company, there is no infringement, misappropriation or violation by third parties of any of the Intellectual Property Rights owned by
the Company or the Subsidiary; (B) there is no pending or, to the knowledge of the Company, threatened action, suit, proceeding or claim
by others challenging the rights of the Company or the Subsidiary in or to any such Intellectual Property Rights, and the Company is unaware
of any facts which would form a reasonable basis for any such claim, that would, individually or in the aggregate, together with any other
claims in this <U>Section 2.34</U>, reasonably be expected to result in a Material Adverse Change; (C) the Intellectual Property Rights
owned by the Company and, to the knowledge of the Company, the Intellectual Property Rights licensed to the Company or the Subsidiary
have not been adjudged by a court of competent jurisdiction invalid or unenforceable, in whole or in part, and there is no pending or,
to the Company&rsquo;s knowledge, threatened action, suit, proceeding or claim by others challenging the validity or scope of any such
Intellectual Property Rights, and the Company is unaware of any facts which would form a reasonable basis for any such claim that would,
individually or in the aggregate, together with any other claims in this <U>Section 2.34</U>, reasonably be expected to result in a Material
Adverse Change; (D) there is no pending or, to the Company&rsquo;s knowledge, threatened action, suit, proceeding or claim by others that
the Company or the Subsidiary infringes, misappropriates or otherwise violates any Intellectual Property Rights or other proprietary rights
of others, neither the Company nor the Subsidiary has received any written notice of such claim and the Company is unaware of any other
facts which would form a reasonable basis for any such claim that would, individually or in the aggregate, together with any other claims
in this <U>Section 2.34</U>, reasonably be expected to result in a Material Adverse Change; and (E) to the Company&rsquo;s knowledge,
no employee of the Company or the Subsidiary is in or has ever been in violation in any material respect of any term of any employment
contract, patent disclosure agreement, invention assignment agreement, non-competition agreement, non-solicitation agreement, nondisclosure
agreement or any restrictive covenant to or with a former employer where the basis of such violation relates to such employee&rsquo;s
employment with the Company or the Subsidiary, or actions undertaken by the employee while employed with the Company or the Subsidiary
and could reasonably be expected to result, individually or in the aggregate, in a Material Adverse Change. To the Company&rsquo;s knowledge,
all material technical information developed by and belonging to the Company or the Subsidiary which has not been patented has been kept
confidential. Neither the Company nor the Subsidiary is a party to or bound by any options, licenses or agreements with respect to the
Intellectual Property Rights of any other person or entity that are required to be set forth in the Registration Statement, the Disclosure
Package and the Prospectus and are not described therein. The Registration Statement, the Disclosure Package and the Prospectus contain
in all material respects the same description of the matters set forth in the preceding sentence. None of the technology employed by the
Company or the Subsidiary has been obtained or is being used by the Company in violation of any contractual obligation binding on the
Company or the Subsidiary or, to the Company&rsquo;s knowledge, any of their officers, directors or employees, or otherwise in violation
of the rights of any persons. </FONT></FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">2.35&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Taxes</U>. Each of the Company and the Subsidiary has filed all returns (as hereinafter defined) required to be filed with taxing authorities
prior to the date hereof or has duly obtained extensions of time for the filing thereof. Each of the Company and the Subsidiary has paid
all taxes (as hereinafter defined) shown as due on such returns that were filed and has paid all taxes imposed on or assessed against
the Company or the Subsidiary. The provisions for taxes payable, if any, shown on the financial statements filed with or as part of the
Registration Statement are sufficient for all accrued and unpaid taxes, whether or not disputed, and for all periods to and including
the dates of such consolidated financial statements. Except as disclosed in writing to the Underwriter, (i) no issues have been raised
(and are currently pending) by any taxing authority in connection with any of the returns or taxes asserted as due from the Company or
the Subsidiary, and (ii) no waivers of statutes of limitation with respect to the returns or collection of taxes have been given by or
requested from the Company or the Subsidiary. There are no tax liens against the assets, properties or business of the Company or the
Subsidiary. The term &ldquo;</FONT><FONT STYLE="font-style: normal">taxes<FONT STYLE="font-weight: normal">&rdquo; means all federal,
state, local, foreign and other net income, gross income, gross receipts, sales, use, ad valorem, transfer, franchise, profits, license,
lease, service, service use, withholding, payroll, employment, excise, severance, stamp, occupation, premium, property, windfall profits,
customs, duties or other taxes, fees, assessments or charges of any kind whatever, together with any interest and any penalties, additions
to tax or additional amounts with respect thereto. The term &ldquo;</FONT>returns<FONT STYLE="font-weight: normal">&rdquo; means all returns,
declarations, reports, statements and other documents required to be filed in respect to taxes.</FONT></FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">2.36&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Compliance with Environmental Laws</U>. Except as described in the Registration Statement, the Disclosure Package and the Prospectus
and except as would not, singly or in the aggregate, result in a Material Adverse Change, (i) neither the Company nor the Subsidiary is
in violation of any federal, state, local or foreign statute, law, rule, regulation, ordinance, code, policy or rule of common law or
any judicial or administrative interpretation thereof, including any judicial or administrative order, consent, decree or judgment, relating
to pollution or protection of human health, the environment (including, without limitation, ambient air, surface water, groundwater, land
surface or subsurface strata) or wildlife, including, without limitation, laws and regulations relating to the release or threatened release
of chemicals, pollutants, contaminants, wastes, toxic substances, hazardous substances, petroleum or petroleum products (collectively,
 &ldquo;</FONT><FONT STYLE="font-style: normal">Hazardous Materials<FONT STYLE="font-weight: normal">&rdquo;) or to the manufacture, processing,
distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials (collectively, &ldquo;</FONT>Environmental
Laws<FONT STYLE="font-weight: normal">&rdquo;), (ii) each of the Company and the Subsidiary has all material permits, authorizations and
approvals required under any applicable Environmental Laws and is in compliance with their requirements, (iii) there are no pending or,
to the Company&rsquo;s knowledge, threatened administrative, regulatory or judicial actions, suits, demands, demand letters, claims, liens,
notices of noncompliance or violation, investigation or proceedings relating to any Environmental Law against the Company or the Subsidiary
and (iv) to the Company&rsquo;s knowledge, there are no events, conditions, incidents or circumstances that might reasonably be expected
to form the basis of an order for clean-up or remediation, or an action, suit or proceeding by any private party or governmental body
or agency, against or affecting the Company or the Subsidiary relating to Hazardous Materials or any Environmental Laws.</FONT></FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">2.37&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>ERISA Compliance</U>. The Company, the Subsidiary and any &ldquo;employee benefit plan&rdquo; (as defined under the Employee Retirement
Income Security Act of 1974, as amended, and the regulations and published interpretations thereunder (collectively, &ldquo;</FONT><FONT STYLE="font-style: normal">ERISA<FONT STYLE="font-weight: normal">&rdquo;))
established or maintained by the Company or its &ldquo;ERISA Affiliates&rdquo; (as defined below) are in compliance in all material respects
with ERISA. &ldquo;</FONT>ERISA Affiliate<FONT STYLE="font-weight: normal">&rdquo; means, with respect to the Company, any member of any
group of organizations described in Sections 414(b),(c),(m) or (o) of the Internal Revenue Code of 1986, as amended, and the regulations
and published interpretations thereunder (the &ldquo;</FONT>Code<FONT STYLE="font-weight: normal">&rdquo;) of which the Company is a member.
No &ldquo;reportable event&rdquo; (as defined under ERISA) has occurred or is reasonably expected to occur with respect to any &ldquo;employee
benefit plan&rdquo; established or maintained by the Company or any of its ERISA Affiliates. No &ldquo;employee benefit plan&rdquo; established
or maintained by the Company or any of its ERISA Affiliates, if such &ldquo;employee benefit plan&rdquo; were terminated, would have any
 &ldquo;amount of unfunded benefit liabilities&rdquo; (as defined under ERISA). Neither the Company nor any of its ERISA Affiliates has
incurred or reasonably expects to incur any material liability under (i) Title IV of ERISA with respect to termination of, or withdrawal
from, any &ldquo;employee benefit plan&rdquo; or (ii) Sections 412, 4971, 4975 or 4980B of the Code. Each &ldquo;employee benefit plan&rdquo;
established or maintained by the Company or any of its ERISA Affiliates that is intended to be qualified under Section 401(a) of the Code
is so qualified and, to the knowledge of the Company, nothing has occurred, whether by action or failure to act, which would cause the
loss of such qualification. The execution of this Agreement, or consummation of the Offering does not constitute a triggering event under
any employee benefit plan or any other employment contract, whether or not legally enforceable, which (either alone or upon the occurrence
of any additional or subsequent event) will or may result in any payment (of severance pay or otherwise), acceleration, increase in vesting,
or increase in benefits to any current or former participant, employee or director of the Company other than an event that is not material
to the financial condition or business of the Company and the Subsidiary taken as a whole.</FONT></FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">2.38&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Compliance with Laws</U>. Each of the Company and the Subsidiary: (A) is and at all times has been in material compliance with all
statutes, rules, or regulations applicable to the conduct of the business of the Company or the Subsidiary (collectively, the &ldquo;</FONT><FONT STYLE="font-style: normal">Applicable
Laws<FONT STYLE="font-weight: normal">&rdquo;), except as could not, individually or in the aggregate, reasonably be expected to have
a Material Adverse Change; (B) has not received any warning letter, untitled letter or other correspondence or notice from any other Governmental
Entity alleging or asserting noncompliance with any Applicable Laws or any Authorizations; (C) possesses all material Authorizations and
such Authorizations are valid and in full force and effect and the Company is not in material violation of any term of any such Authorizations;
(D) has not received notice of any claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration or other action from
any Governmental Entity or third party alleging that any of the Company&rsquo;s activities is in violation of any Applicable Laws or Authorizations
and has no knowledge that any such Governmental Entity or third party is considering any such claim, litigation, arbitration, action,
suit, investigation or proceeding; (E) has not received notice that any Governmental Entity has taken, is taking or intends to take action
to limit, suspend, modify or revoke any Authorizations and has no knowledge that any such governmental authority is considering such action;
and (F) has filed, obtained, maintained or submitted all material reports, documents, forms, notices, applications, records, claims, submissions
and supplements or amendments as required by any Applicable Laws or Authorizations and that all such reports, documents, forms, notices,
applications, records, claims, submissions and supplements or amendments were complete and correct on the date filed (or were corrected
or supplemented by a subsequent submission).</FONT></FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">2.39&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Company IT Systems</U>. Except as described in the Registration Statement, the Disclosure Package and the Prospectus, the Company owns
or has a valid right to access and use all computer systems, networks, hardware, software, databases, websites and equipment used to process,
store, maintain and operate data, information and functions necessary for the conduct of its business (the &ldquo;</FONT><FONT STYLE="font-style: normal">Company
IT Systems<FONT STYLE="font-weight: normal">&rdquo;), except where the failure to own or have the right to access the Company IT Systems
would not reasonably be expected to have a Material Adverse Effect. The Company IT Systems are adequate for, and operate and perform in
all material respects as required in connection with, the operation of the business of the Company as currently conducted except as would
not be reasonably expected, individually or in the aggregate, to have a Material Adverse Effect.</FONT></FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">2.40&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Smaller Reporting Company</U>.&nbsp; As of the effective date of the Registration Statement and the date of this Agreement, the Company
was a &ldquo;smaller reporting company,&rdquo; as defined in Rule&nbsp;12b-2 of the Exchange Act Regulations.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">2.41&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Industry Data</U>.&nbsp; The statistical and market-related data included in each of the Registration Statement, the Disclosure Package
and the Prospectus are based on or derived from sources that the Company reasonably and in good faith believes are reliable and accurate
or represent the Company&rsquo;s good faith estimates that are made on the basis of data derived from such sources.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">2.42&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Margin Securities</U>. Neither the Company nor the Subsidiary owns any &ldquo;margin securities&rdquo; as that term is defined in Regulation
U of the Board of Governors of the Federal Reserve System (the &ldquo;</FONT><FONT STYLE="font-style: normal">Federal Reserve Board<FONT STYLE="font-weight: normal">&rdquo;),
and none of the proceeds of the Offering will be used, directly or indirectly, for the purpose of purchasing or carrying any margin security,
for the purpose of reducing or retiring any indebtedness which was originally incurred to purchase or carry any margin security or for
any other purpose which might cause any of the shares of Common Stock to be considered a &ldquo;purpose credit&rdquo; within the meanings
of Regulation T, U or X of the Federal Reserve Board.</FONT></FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">2.43&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Integration</U>. Neither the Company nor the Subsidiary or affiliates, nor any person acting on its or their behalf has, directly or
indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause
the Offering to be integrated with prior offerings by the Company for purposes of the Securities Act that would require the registration
of any such securities under the Securities Act.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">2.44&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Title to Real and Personal Property</U>. Each of the Company and the Subsidiary has good and marketable title in fee simple to, or
has valid rights to lease or otherwise use, all items of real or personal property that are material to the business of the Company and
the Subsidiary taken as a whole, free and clear of all liens, encumbrances, security interests, claims and defects that do not, singularly
or in the aggregate, result in a Material Adverse Change and do not interfere with the use made of such property by the Company or the
Subsidiary; and all of the leases and subleases material to the business of the Company and the Subsidiary taken as a whole, and under
which the Company or the Subsidiary holds properties described in the Registration Statement, the Disclosure Package and the Prospectus,
are, to the Company&rsquo;s knowledge in full force and effect, and neither the Company nor the Subsidiary has received any notice of
any material claim of any sort that has been asserted by anyone adverse to the rights of the Company or the Subsidiary under any of the
leases or subleases mentioned above, or affecting or questioning the rights of the Company or the Subsidiary to the continued possession
of the leased or subleased premises under any such lease or sublease, which would result in a Material Adverse Change.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">2.45&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Confidentiality
and Non-Competition Agreements.</U> To the Company&rsquo;s knowledge, no director, officer, key employee or consultant of the Company
or the Subsidiary is subject to any confidentiality, non-disclosure, non-competition agreement or non-solicitation agreement with any
employer or prior employer that could materially affect his ability to be and act in his respective capacity of the Company or the Subsidiary
or result in a Material Adverse Change.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">2.46&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Corporate Records</U>. The minute books of the Company and the Subsidiary have been made available to the Underwriter and the Underwriter&rsquo;s
Counsel, and such books (i) contain a summary of all meetings and actions of the board of directors (including each board committee) and
shareholders of the Company, and (ii) reflect all material transactions referred to in such minutes.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">2.47&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Diligence Materials</U>. The Company has provided to the Company and the Underwriter&rsquo;s Counsel all materials responsive in all
material respects to the diligence requests, if any, submitted to the Company or its counsel by the Underwriter.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">2.48&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Nasdaq Marketplace Rules</U></FONT><FONT STYLE="font-weight: normal">. <FONT STYLE="font-style: normal">&#9;The Company is, and after
giving effect to the Offering will be, in compliance in all material respects with all applicable corporate governance requirements set
forth in the Nasdaq Marketplace Rules.</FONT></FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-weight: normal">3.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-weight: normal"><U>Covenants of the Company</U>.
The Company covenants and agrees as follows:</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">3.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendments to Registration Statement</U>. The Company shall deliver to the Underwriter, prior to filing, any amendment or supplement
to the Registration Statement, any Preliminary Prospectus, any issuer Free Writing Prospectus, the Disclosure Package or the Prospectus
proposed to be filed after the Effective Date and not file any such amendment, supplement or document to which the Underwriter shall reasonably
object in writing. </FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">3.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Federal Securities Laws</U>.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">3.2.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Compliance</U>. The Company, subject to <U>Section 3.2.2</U>, shall comply with the requirements of Rule 424(b) and Rule 430B of the
Securities Act Regulations, and will notify the Underwriter promptly, and confirm the notice in writing, (i)&nbsp;when any post-effective
amendment to the Registration Statement or any amendment or supplement to any Preliminary Prospectus, the Disclosure Package or the Prospectus
shall have been filed and when any post-effective amendment to the Registration Statement shall become effective; (ii)&nbsp;of the receipt
of any comments from the Commission; (iii)&nbsp;of any request by the Commission for any amendment to the Registration Statement or any
amendment or supplement to any Preliminary Prospectus, the Disclosure Package or the Prospectus or for additional information; (iv)&nbsp;of
the issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement or any post-effective amendment
or of any order preventing or suspending the use of any Preliminary Prospectus or the Prospectus, or of the suspension of the qualification
of the Public Securities for offering or sale in any jurisdiction, or of the initiation or threatening of any proceedings for any of such
purposes or of any examination pursuant to Section&nbsp;8(d) or 8(e) of the Securities Act concerning the Registration Statement; and
(v)&nbsp;if the Company becomes the subject of a proceeding under Section 8A of the Securities Act in connection with the Offering of
the Public Securities. The Company shall effect all filings required under Rule 424(b) of the Securities Act Regulations, in the manner
and within the time period required by Rule 424(b) (without reliance on Rule 424(b)(8)), and shall take such steps as it deems necessary
to ascertain promptly whether the form of prospectus transmitted for filing under Rule 424(b) was received for filing by the Commission
and, in the event that it was not, it will promptly file such prospectus. The Company shall use its commercially reasonable efforts to
prevent the issuance of any stop order, prevention or suspension and, if any such order is issued, to obtain the lifting thereof at the
earliest possible moment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">3.2.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Continued
Compliance.</U> The Company shall comply with the Securities Act, the Securities Act Regulations, the Exchange Act and the Exchange Act
Regulations so as to permit the completion of the distribution of the Public Securities as contemplated in this Agreement and in the
Registration Statement, the Disclosure Package and the Prospectus. If at any time when a prospectus relating to the Public Securities
is (or, but for the exception afforded by Rule 172 of the Securities Act Regulations (&ldquo;</FONT>Rule 172<FONT STYLE="font-weight: normal">&rdquo;),
would be) required by the Securities Act to be delivered in connection with sales of the Public Securities, any event shall occur or
condition shall exist as a result of which it is necessary, in the opinion of Underwriter&rsquo;s Counsel or Company Counsel (as defined
below), to (i)&nbsp;amend the Registration Statement in order that the Registration Statement will not include an untrue statement of
a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading;
(ii)&nbsp;amend or supplement the Disclosure Package or the Prospectus in order that the Disclosure Package or the Prospectus, as the
case may be, will not include any untrue statement of a material fact or omit to state a material fact necessary in order to make the
statements therein not misleading in the light of the circumstances existing at the time it is delivered to a purchaser; or (iii)&nbsp;amend
the Registration Statement or amend or supplement the Disclosure Package or the Prospectus, as the case may be, in order to comply with
the requirements of the Securities Act or the Securities Act Regulations, the Company will promptly (A)&nbsp;give the Underwriter notice
of such event; (B)&nbsp;prepare any amendment or supplement as may be necessary to correct such statement or omission or to make the
Registration Statement, the Disclosure Package or the Prospectus comply with such requirements and, a reasonable amount of time prior
to any proposed filing or use, furnish the Underwriter with copies of any such amendment or supplement; and (C)&nbsp;file with the Commission
any such amendment or supplement; <I>provided, however</I>, that the Company shall not file or use any such amendment or supplement to
which the Underwriter or Underwriter&rsquo;s Counsel shall reasonably object. The Company will furnish to the Underwriter such number
of copies of such amendment or supplement as the Underwriter may reasonably request. The Company will give the Underwriter notice of
its intention to make any such filing from the Applicable Time until the earlier of the last Option Closing Date, if any, and the expiration
date of the Overallotment Option and will furnish the Underwriter with copies of the related document(s) a reasonable amount of time
prior to such proposed filing, as the case may be, and will not file or use any such document to which the Underwriter or Underwriter&rsquo;s
Counsel shall reasonably object. </FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">3.2.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Exchange Act Registration</U>. For a period of two (2) years after the date of this Agreement, the Company shall use its commercially
reasonable efforts to maintain the registration of the Common Stock under the Exchange Act. For a period of two (2) years after the date
of this Agreement, the Company shall not deregister the Common Stock under the Exchange Act without the prior written consent of the Underwriter,
which consent shall not unreasonably be withheld.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">3.2.3.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Free Writing Prospectuses.</U>&nbsp;The Company agrees that, unless it obtains the prior written consent of the Underwriter, it shall
not make any offer relating to the Public Securities that would constitute an Issuer Free Writing Prospectus or that would otherwise constitute
a &ldquo;free writing prospectus,&rdquo; or a portion thereof, required to be filed by the Company with the Commission or retained by
the Company under Rule 433; <I><U>provided</U></I> that the Underwriter shall be deemed to have consented to each Issuer General Use Free
Writing Prospectus listed in <U>Schedule 1-B</U> and any &ldquo;road show that is a written communication&rdquo; within the meaning of
Rule 433(d)(8)(i) that has been reviewed by the Underwriter. The Company represents that it has treated or agrees that it will treat each
such free writing prospectus consented to, or deemed consented to, by the Underwriter as an &ldquo;issuer free writing prospectus,&rdquo;
as defined in Rule 433, and that it has complied and will comply with the applicable requirements of Rule 433 with respect thereto, including
timely filing with the Commission where required, legending and record keeping. If at any time following issuance of an Issuer Free Writing
Prospectus there occurred or occurs an event or development as a result of which such Issuer Free Writing Prospectus conflicted or would
conflict with the information contained in the Registration Statement or included or would include an untrue statement of a material fact
or omitted or would omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances
existing at that subsequent time, not misleading, the Company will promptly notify the Underwriter and will promptly amend or supplement,
at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement or omission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">3.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Delivery to the Underwriter of Registration Statements</U>. The Company has delivered or made available or shall deliver or make available
to the Underwriter and Underwriter&rsquo;s Counsel, without charge, signed copies of the Registration Statement as originally filed and
each amendment thereto (including exhibits filed therewith) and signed copies of all consents and certificates of experts, and will also
deliver to the Underwriter, without charge, a conformed copy of the Registration Statement as originally filed and each amendment thereto
(without exhibits) for the Underwriter. The copies of the Registration Statement and each amendment thereto furnished to the Underwriter
will be identical to the electronically transmitted copies thereof filed with the Commission pursuant to EDGAR, except to the extent permitted
by Regulation S-T.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">3.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Delivery to the Underwriter of Prospectuses</U>. The Company has delivered or made available or will deliver or make available to the
Underwriter, without charge, as many copies of each Preliminary Prospectus and the Disclosure Package as the Underwriter reasonably requests,
and the Company hereby consents to the use of such copies for purposes permitted by the Securities Act. The Company will furnish to the
Underwriter, without charge, during the period when a prospectus relating to the Public Securities is (or, but for the exception afforded
by Rule 172 of the Securities Act Regulations, would be) required to be delivered under the Securities Act, such number of copies of the
Prospectus (as amended or supplemented) as the Underwriter may reasonably request. The Prospectus and any amendments or supplements thereto
furnished to the Underwriter will be identical to the electronically transmitted copies thereof filed with the Commission pursuant to
EDGAR, except to the extent permitted by Regulation S-T.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">3.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Effectiveness and Events Requiring Notice to the Underwriter</U>. The Company shall use commercially reasonable efforts to cause the
Registration Statement to remain effective with a current prospectus for at least nine (9) months after the Applicable Time. The Company
shall notify the Underwriter immediately and confirm the notice in writing: (i)&nbsp;of the effectiveness of the Registration Statement
and any amendment thereto; (ii)&nbsp;of the issuance by the Commission of any stop order or of the initiation, or the threatening, of
any proceeding for that purpose; (iii)&nbsp;of the issuance by any state securities commission of any proceedings for the suspension of
the qualification of the Public Securities for offering or sale in any jurisdiction or of the initiation, or the threatening, of any proceeding
for that purpose; (iv)&nbsp;of the mailing and delivery to the Commission for filing of any amendment or supplement to the Registration
Statement or Prospectus; (v)&nbsp;of the receipt of any comments or request for any additional information from the Commission; and (vi)&nbsp;of
the happening of any event during the period described in this <U>Section 3.5</U> that, in the judgment of the Company, makes any statement
of a material fact made in the Registration Statement, the Disclosure Package or the Prospectus untrue or that requires the making of
any changes in (a) the Registration Statement in order to make the statements therein not misleading, or (b) in the Disclosure Package
or the Prospectus in order to make the statements therein, in light of the circumstances under which they were made, not misleading. If
the Commission or any state securities commission shall enter a stop order or suspend such qualification at any time, the Company shall
make every reasonable effort to obtain promptly the lifting of such order.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">3.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Review
of Financial Statements.</U> For a period of three (3) years after the date of this Agreement, the Company, at its expense, shall cause
its regularly engaged independent registered public accounting firm to review (but not audit) the Company&rsquo;s financial statements
for each of the three fiscal quarters immediately preceding the announcement of any quarterly financial information.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">3.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Listing</U>. The Company shall use its commercially reasonable efforts to maintain the listing of the Common Stock (including the Public
Securities) on the NasdaqCM for at least two (2) years from the date of this Agreement.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">3.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Reports to the Underwriter</U>.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">3.8.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Periodic Reports</U>. For a period of two (2) years after the date of this Agreement, the Company shall furnish or make available to
the Underwriter copies of such financial statements and other periodic and special reports as the Company from time to time furnishes
generally to holders of any class of its securities and also promptly furnish to the Underwriter: (i) a copy of each periodic report the
Company shall be required to file with the Commission under the Exchange Act and the Exchange Act Regulations; (ii) a copy of every press
release and every news item and article with respect to the Company or its affairs which was released by the Company; (iii) a copy of
each Form 8-K prepared and filed by the Company; (iv) five copies of each registration statement filed by the Company under the Securities
Act; (v) a copy of each report or other communication furnished to shareholders; and (vi) such additional documents and information with
respect to the Company and the affairs of any future subsidiaries of the Company as the Underwriter may from time to time reasonably request;
provided the Underwriter shall sign, if requested by the Company, a Regulation FD compliant confidentiality agreement which is reasonably
acceptable to the Underwriter and Underwriter&rsquo;s Counsel in connection with the Underwriter&rsquo;s receipt of such information.
Documents filed with the Commission pursuant to its EDGAR system shall be deemed to have been delivered to the Underwriter pursuant to
this <U>Section 3.8.1</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">3.8.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Transfer Agent; Transfer Sheets</U>. For a period of two (2) years after the date of this Agreement, the Company shall retain a transfer
agent and registrar acceptable to the Underwriter (the&nbsp;&ldquo;</FONT>Transfer Agent<FONT STYLE="font-weight: normal">&rdquo;). VStock
Transfer, LLC is acceptable to the Underwriter to act as Transfer Agent for the Common Stock. </FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">3.8.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Trading Reports</U>. For a period of two (2) years after the date of this Agreement, the Company shall provide to the Underwriter,
at the Company&rsquo;s expense, such reports published by NasdaqCM relating to price trading of the Public Securities, as the Underwriter
shall reasonably request; provided that such provision shall not prevent a sale, merger or similar transaction involving the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">3.8.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Payment of Expenses</U>. The Company hereby agrees to pay on the Closing Date and each Option Closing Date, if any, to the extent not
paid at the Closing Date, all expenses incident to the performance of the obligations of the Company under this Agreement, including,
but not limited to: (a) all filing fees and communication expenses relating to the registration of the Public Securities to be sold in
the Offering (including the Additional Shares) with the Commission, (b) all filing fees and other expenses (including the reasonable fees
and disbursements of counsel to the Underwriter) incurred in connection with qualification of the Public Securities for sale under the
laws of such jurisdictions as the Underwriter designates, (c) costs and expenses related to the review of the Offering by FINRA, including
all filing fees and the reasonable fees and disbursements of counsel to the Underwriter relating to such review, (d) costs and reasonable
expenses relating to investor presentations or any &ldquo;road show&rdquo; in connection with the Offering, including, without limitation,
the costs of recording and hosting on the Internet of the Company&rsquo;s road show presentation and any reasonable travel expenses of
the Company&rsquo;s officers and employees and any other expenses of the Company, (e) fees and expenses incident to listing or continued
listing of the Public Securities on the NasdaqCM and on such other stock exchanges as the Company and the Underwriter together determine,
(f) the fees, disbursements and expenses of the Company&rsquo;s counsel, accountants and other advisors in connection with the Offering,
(g) expenses incurred in preparing, printing and distributing each Preliminary Prospectus and the Prospectus (including any amendments
and supplements thereto) to the Underwriter and for expenses incurred for preparing, printing and distributing any issuer free writing
prospectuses to investors or prospective investors, (h) reasonable fees, disbursements and expenses of the Underwriter&rsquo;s counsel,
(i) the costs and expenses of a public relations firm selected by the Company, if any, (i) the costs of preparing, printing and delivering
certificates representing the Public Securities, (j) fees and expenses of the transfer agent for the delivery of the Public Securities
of Shares, (k) stock transfer and/or stamp taxes, if any, payable upon the transfer of securities from the Company to the Underwriter,
(l) to the extent approved by the Company in writing, the costs associated with post-closing advertising of the Offering in the national
editions of the Wall Street Journal and New York Times, (m) fees, expenses and disbursements relating to background checks of the Company&rsquo;s
officers and directors in connection with the Offering; <U>provided</U>, <U>however</U>, that the maximum amount of fees, costs and expenses
incurred by the Underwriter with respect to subparagraphs <U>(a)</U> through <U>(m)</U> above, including, without limitation, the fees,
disbursements and expenses of counsel to the Underwriter, that the Company shall be required to pay under this <U>Section 3.8.4</U> shall
not exceed $80,000. The Underwriter may deduct from the net proceeds of the Offering payable to the Company on the Closing Date or any
Option Closing Date, the expenses set forth herein to be paid by the Company to the Underwriter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">3.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Application of Net Proceeds</U>. The Company shall apply the net proceeds from the Offering received by it in a manner consistent with
the application thereof described under the caption &ldquo;Use of Proceeds&rdquo; in the Registration Statement, the Disclosure Package
and the Prospectus.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">3.10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Delivery of Earnings Statements to Security Holders</U>. The Company shall make generally available to its security holders as soon
as practicable, but not later than the first day of the fifteenth (15<SUP>th</SUP>) full calendar month following the date of this Agreement,
an earnings statement (which need not be certified by an independent registered public accounting firm unless required by the Securities
Act or the Securities Act Regulations, but which shall satisfy the provisions of Rule 158(a) under Section 11(a) of the Securities Act)
covering a period of at least twelve (12) consecutive months ending after the date of this Agreement.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">3.11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Stabilization</U>. Neither the Company nor, to its knowledge, any of its employees, directors or shareholders (without the consent
of the Underwriter), has taken or shall take, directly or indirectly, any action designed to or that has constituted or that might reasonably
be expected to cause or result in, under Regulation M of the Exchange Act, or otherwise, stabilization or manipulation of the price of
any security of the Company to facilitate the sale or resale of the Public Securities.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">3.12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Internal Controls</U>. The Company shall use commercially reasonable efforts to maintain a system of internal accounting controls sufficient
to provide reasonable assurances regarding the reliability of financial reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting principles and includes those policies and procedures that: (1) pertain to the
maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the
Company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in
accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance
with authorizations of management and directors of the issuer; and (3) provide reasonable assurance regarding prevention or timely detection
of unauthorized acquisition, use or disposition of the Company&rsquo;s assets that could have a material effect on the financial statements.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">3.13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Accountants</U>. The Company shall retain an independent registered public accounting firm, as required by the Securities Act and the
Regulations and the Public Company Accounting Oversight Board, reasonably acceptable to the Underwriter, and the Company shall continue
to retain an independent registered public accounting firm for a period of at least three (3) years after the date of this Agreement.
The Underwriter acknowledges that the Current Auditor is acceptable to the Underwriter.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">3.14&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>FINRA</U>. For a period of 90 days from the later of the Closing Date or the last Option Closing Date, if any, the Company shall advise
the Underwriter (who shall make an appropriate filing with FINRA) if it is or becomes aware that (i) any officer or director of the Company,
(ii) any beneficial owner of 5% or more of any class of the Company&rsquo;s securities, or (iii) any beneficial owner of the Company&rsquo;s
unregistered equity securities which were acquired during the 180 days immediately preceding the filing of the Registration Statement
is or becomes an affiliate or associated person of a FINRA member participating in the Offering (as determined in accordance with the
rules and regulations of FINRA).</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">3.15&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Fiduciary Duties.</U> The Company acknowledges and agrees that the Underwriter&rsquo;s responsibility to the Company is solely contractual
in nature and that none of the Underwriter or its affiliates or any selling agent shall be deemed to be acting in a fiduciary capacity,
or otherwise owes any fiduciary duty to the Company or any of its affiliates in connection with the Offering and the other transactions
contemplated by this Agreement.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">3.16&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Company Lock-Up Agreements</U>.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">3.16.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Restriction on Sales of Capital Stock</U>. The Company, on behalf of itself and any successor entity, agrees that, without the prior
written consent of the Underwriter, it will not, for a period of ninety (90) days after the date of this Agreement (the &ldquo;</FONT>Lock-Up
Period<FONT STYLE="font-weight: normal">&rdquo;), (a) offer, pledge, sell, contract to sell, sell any option or contract to purchase,
purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly
or indirectly, any shares of capital stock of the Company or any securities convertible into or exercisable or exchangeable for shares
of capital stock of the Company, (b) file or cause to be filed any registration statement with the Commission relating to the offering
of any shares of capital stock of the Company or any securities convertible into or exercisable or exchangeable for shares of capital
stock of the Company or (c) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic
consequences of ownership of capital stock of the Company, whether any such transaction described in <U>clause (a)</U>, <U>(b)</U> or
<U>(c)</U> above is to be settled by delivery of shares of capital stock of the Company or such other securities, in cash or otherwise.
The restrictions contained in this <U>Section 3.16.1</U> shall not apply to (i)&nbsp;sales of shares of capital stock of the Company under
any trading plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, existing as of the date of the Underwriting
Agreement, (ii) the Public Securities to be sold hereunder, (iii) the issuance by the Company of shares of capital stock of the Company
upon the exercise of a stock option or warrant or the conversion or vesting of a security outstanding on the date hereof, (iv) the issuance
by the Company of equity awards of the Company under any equity compensation plan of the Company, including but not limited to the Company&rsquo;s
2021 Equity Incentive Plan and the Company&rsquo;s 2013 Consultant Plan (as amended from time to time), (v) the issuance by the Company
of shares of capital stock of the Company or securities convertible into, exchangeable for or that represent the right to receive shares
of capital stock of the Company in connection with the acquisition by the Company of the securities, business, technology, property or
other assets of another person or entity, (vi) the sale of shares of capital stock of the Company to cover the payment of exercise prices
or the payment of taxes associated with the exercise or vesting of equity awards under any equity compensation plan of the Company, (vii)
shares issued to clirSPV LLC pursuant to the purchase rights described in the &ldquo;Underwriting&rdquo; Section of the Prospectus, or
(viii) shares issued pursuant to the ATM Sales Agreement, provided, however that no shares shall be issued pursuant to the ATM Sales Agreement
for a period of thirty (30) days after the date of this Agreement, unless otherwise agreed to by the Underwriter.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">3.16.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Restriction on Continuous Offerings</U>. Notwithstanding the restrictions and exceptions contained in <U>Section 3.16.1</U>, the Company,
on behalf of itself and any successor entity, agrees that, without the prior written consent of the Underwriter, it will not, for a period
of ninety (90) days after the date of this Agreement, directly or indirectly in any &ldquo;at-the-market&rdquo; or continuous equity transaction,
offer to sell, sell, contract to sell, grant any option to sell or otherwise dispose of shares of capital stock of the Company or any
securities convertible into or exercisable or exchangeable for shares of capital stock of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">3.17&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Release of Lock-up Period</U>. If the Underwriter, in its sole discretion, agrees to release or waive the restrictions set forth in
the Lock-Up Agreements described in <U>Section 2.24</U> for an officer or director of the Company and provide the Company with notice
of the impending release or waiver at least three (3) Business Days before the effective date of the release or waiver, the Company agrees
to announce the impending release or waiver by a press release substantially in the form of <U>Exhibit B</U> hereto through a major news
service at least two (2) Business Days before the effective date of the release or waiver.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">3.18&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Blue
Sky Qualifications</U>. The Company shall use commercially reasonable efforts, in cooperation with the Underwriter, if necessary, to
qualify the Public Securities for offering and sale under the applicable securities laws of such states and other jurisdictions (domestic
or foreign) as the Underwriter may designate and to maintain such qualifications in effect so long as required to complete the distribution
of the Public Securities; </FONT><FONT STYLE="font-weight: normal">provided, however, <FONT STYLE="font-style: normal">that the Company
shall not be obligated to file any general consent to service of process or to qualify as a foreign corporation or as a dealer in securities
in any jurisdiction in which it is not so qualified or to subject itself to taxation in respect of doing business in any jurisdiction
in which it is not otherwise so subject.</FONT></FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">3.19&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Reporting Requirements</U>. The Company, during the period when a prospectus relating to the Public Securities is (or, but for the
exception afforded by Rule 172, would be) required to be delivered under the Securities Act, will file all documents required to be filed
with the Commission pursuant to the Exchange Act within the time periods required by the Exchange Act and Exchange Act Regulations.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">3.20&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Press Releases</U>. Prior to the Closing Date and any Option Closing Date, the Company shall not issue any press release or other communication
directly or indirectly or hold any press conference with respect to the Company, its condition, financial or otherwise, or earnings, business
affairs or business prospects (except for routine oral marketing communications in the ordinary course of business and consistent with
the past practices of the Company and of which the Underwriter is notified), without the prior written consent of the Underwriter, which
consent shall not be unreasonably withheld, unless in the reasonable judgment of the Company and its counsel, and after notification to
the Underwriter, such press release or communication is required by law.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">3.21&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Sarbanes-Oxley</U>. The Company shall use commercially reasonable efforts to comply with all applicable provisions of the Sarbanes-Oxley
Act in effect from time to time.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">3.22&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>IRS Forms</U>. The Company shall deliver to each Underwriter (or its agent), prior to or at the Closing Date, a properly completed
and executed Internal Revenue Service (&ldquo;</FONT><FONT STYLE="font-style: normal">IRS<FONT STYLE="font-weight: normal">&rdquo;) Form
W-9 or an IRS Form W-8, as appropriate, together with all required attachments to such form.</FONT></FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-weight: normal">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Conditions of Underwriter&rsquo;s Obligations</U>. The obligations of the Underwriter to purchase and pay for the Public Securities,
as provided herein, shall be subject to (i) the continuing accuracy of the representations and warranties of the Company as of the date
hereof, as of the Closing Date and each Option Closing Date, as applicable; (ii) the accuracy of the statements of officers of the Company
made pursuant to the provisions hereof; (iii) the performance by the Company of its obligations hereunder; and (iv) the following conditions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">4.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Regulatory Matters</U>.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">4.1.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Absence of Certain Commission Actions; Required Filings</U>. The Registration Statement is effective under the Securities Act, no stop
order suspending the effectiveness of the Registration Statement or any post-effective amendment thereto has been issued under the Securities
Act, no order preventing or suspending the use of any Preliminary Prospectus, the Prospectus or any part thereof shall have been issued
and no proceedings for that purpose or pursuant to Section 8A under the Securities Act shall have been initiated or threatened by the
Commission, and all requests for additional information on the part of the Commission (to be included or incorporated by reference in
the Registration Statement or the Prospectus or otherwise) shall have been complied with to the reasonable satisfaction of the Underwriter.
The Prospectus containing the Rule 430A Information shall have been filed with the Commission in the manner and within the time frame
required by Rule 424(b) of the Securities Act Regulations (without reliance on Rule 424(b)(8)) or a post-effective amendment providing
such information shall have been filed with, and declared effective by, the Commission in accordance with the requirements of Rule 430B
under the Securities Act Regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">4.1.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>FINRA Clearance</U>. The non-objection letter issued by FINRA with respect to the Registration Statement shall not have been rescinded,
withdrawn or suspended, nor shall FINRA have raised any subsequent objection to, or issued comments with respect to, the amount of compensation
allowable or payable to the Underwriter as described in the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">4.1.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>NasdaqCM Market Clearance</U>. The Company shall have submitted the Listing of Additional Shares Notification Form to the NasdaqCM
with respect to the Offering of the Public Securities and the Exchange shall not have raised any objection to the submission prior the
Closing Date or each Option Closing Date, as applicable. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">4.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Counsel Matters</U>.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">4.2.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Closing Date Opinion of Counsel to the Company</U>. On the Closing Date and each Option Closing Date, if any, the Underwriter shall
have received: (i) the favorable opinion and negative assurance letter of Mitchell Silberberg &amp; Knupp LLP, counsel to the Company
(&ldquo;</FONT>Company Counsel<FONT STYLE="font-weight: normal">&rdquo;), and (ii) the favorable opinion of Hillis Clark Martin &amp;
Peterson P.S. (&ldquo;</FONT>Washington Counsel<FONT STYLE="font-weight: normal">&rdquo;), in each case, dated the Closing Date and each
Option Closing Date, as applicable, and addressed to the Underwriter in form and substance reasonably satisfactory to the Underwriter.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">4.2.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Opinion of Underwriter&rsquo;s Counsel</U>. On the Closing Date and each Option Closing Date, if any, the Underwriter shall have received
from Underwriter&rsquo;s Counsel negative assurance letter of Underwriter&rsquo;s Counsel, dated the Closing Date and each Option Closing
Date, as applicable. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">4.2.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Reliance</U>. In rendering such opinion, Company Counsel and Washington Counsel may rely: (i)&nbsp;as to matters involving the application
of laws other than the laws of the United States and jurisdictions in which it is admitted, to the extent such counsel deems proper and
to the extent specified in such opinion, if at all, upon an opinion or opinions (in form and substance reasonably satisfactory to the
Underwriter) of other counsel reasonably acceptable to the Underwriter, familiar with the applicable laws; and (ii)&nbsp;as to matters
of fact, to the extent is deems proper, on certificates or other written statements of officers of the Company and officers of departments
of various jurisdictions having custody of documents respecting the corporate existence or good standing of the Company, provided that
copies of any such statements or certificates shall be delivered to Underwriter&rsquo;s Counsel if requested. The opinions of counsel
referred to in <U>Sections 4.2.1</U> above shall include a statement to the effect that it may be relied upon by Underwriter&rsquo;s Counsel
in its opinion delivered to the Underwriter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">4.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Comfort Letters</U>. </FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">4.3.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Cold Comfort Letter</U>. At the time this Agreement is executed you shall have received a cold comfort letter containing statements
and information of the type customarily included in accountants&rsquo; comfort letters with respect to the financial statements and certain
financial information contained in the Registration Statement, the Disclosure Package and the Prospectus, addressed to the Underwriter
and in form and substance satisfactory in all respects to you and to the Auditor, dated as of the date of this Agreement, from each of
the Current Auditor and the Prior Auditor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">4.3.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Bring-down Comfort Letter</U>. At the Closing Date and each Option Closing Date, if any, the Underwriter shall have received from each
of the Current Auditor and the Prior Auditor a letter, dated as of the Closing Date or such Option Closing Date, as applicable, to the
effect that the Current Auditor or Prior Auditor, respectively, reaffirms the statements made in the letter furnished pursuant to <U>Section
4.3.1</U>, except that the specified date referred to shall be a date not more than three (3) Business Days prior to the Closing Date
or Option Closing Date, as applicable. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">4.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Officers&rsquo; Certificates</U>.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">4.4.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Officers&rsquo; Certificate</U>. The Company shall have furnished to the Underwriter a certificate, dated the Closing Date and each
Option Closing Date, as applicable, of its Chief Executive Officer and its Vice President and Controller stating that (i) such officers
have carefully examined the Registration Statement, the Disclosure Package, any Issuer Free Writing Prospectus and the Prospectus and,
in their opinion, the Registration Statement and each amendment thereto, as of the Applicable Time and as of the Closing Date or such
Option Closing Date, as applicable, did not include any untrue statement of a material fact and did not omit to state a material fact
required to be stated therein or necessary to make the statements therein not misleading, and the Disclosure Package, as of the Applicable
Time and as of the Closing Date and such Option Closing Date, as applicable, any Issuer Free Writing Prospectus as of its date and as
of the Closing Date and such Option Closing Date, as applicable, the Prospectus and each amendment or supplement thereto, as of the respective
date thereof and as of the Closing Date or Option Closing Date, as applicable, did not include any untrue statement of a material fact
and did not omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances in which
they were made, not misleading, (ii) since the date of this Agreement, no event has occurred which should have been set forth in a supplement
or amendment to the Registration Statement, the Disclosure Package or the Prospectus, (iii) to the best of their knowledge after reasonable
investigation, as of the Closing Date or such Option Closing Date, as applicable, the representations and warranties of the Company in
this Agreement are true and correct in all material respects, except for such representations and warranties qualified by materiality
or material adverse change which shall be true and correct in all respects and the Company has complied in all material respects with
all agreements and satisfied all conditions on its part to be performed or satisfied hereunder at or prior to the Closing Date or such
Option Closing Date, as applicable, and (iv) there has not been, subsequent to the date of the most recent audited financial statements
included or incorporated by reference in the Disclosure Package, any material adverse change in the financial position or results of operations
of the Company, or any change or development that, singularly or in the aggregate, would involve a material adverse change or a prospective
material adverse change, in or affecting the condition (financial or otherwise), results of operations, business, assets or prospects
of the Company, except as set forth in the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-weight: normal">4.4.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Secretary&rsquo;s Certificate</U>. At the Closing Date and each Option Closing Date, if any, the Underwriter shall have received a
certificate of the Company signed by the Secretary of the Company, dated the Closing Date or such Option Closing Date, as applicable,
certifying: (i)&nbsp;that each of the Charter and the Bylaws is true and complete, has not been modified and is in full force and effect;
(ii)&nbsp;that the resolutions of the Company&rsquo;s Board of Directors and/or any committee thereof relating to the Offering are in
full force and effect and have not been modified; (iii) as to the accuracy and completeness of all correspondence between the Company
or Company Counsel and the Commission; and (iv)&nbsp;as to the incumbency of the officers of the Company. The documents referred to in
such certificate shall be attached to such certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">4.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No Material Changes</U>. Prior to and on the Closing Date and each Option Closing Date: (i)&nbsp;there shall have been no Material
Adverse Change or development involving a prospective material adverse change in the condition or prospects or the business activities,
financial or otherwise, of the Company from the latest dates as of which such condition is set forth in the Registration Statement, the
Disclosure Package and the Prospectus; (ii)&nbsp;no action, suit or proceeding, at law or in equity, shall have been pending or threatened
against the Company or any Insider before or by any court or federal or state commission, board or other administrative agency wherein
an unfavorable decision, ruling or finding may materially adversely affect the business, operations, prospects or financial condition
or income of the Company, except as set forth in the Registration Statement, the Disclosure Package and the Prospectus; (iii)&nbsp;no
stop order shall have been issued under the Securities Act and no proceedings therefor shall have been initiated or threatened by the
Commission; (iv)&nbsp;no action shall have been taken and no law, statute, rule, regulation or order shall have been enacted, adopted
or issued by any Governmental Entity which would prevent the issuance or sale of the Public Securities or materially and adversely affect
or potentially materially and adversely affect the business or operations of the Company or the Subsidiary; (v) no injunction, restraining
order or order of any other nature by any federal or state court of competent jurisdiction shall have been issued which would prevent
the issuance or sale of the Public Securities or materially and adversely affect or potentially materially and adversely affect the business
or operations of the Company or the Subsidiary; and (vi) the Registration Statement, the Disclosure Package and the Prospectus and any
amendments or supplements thereto shall contain all material statements which are required to be stated therein in accordance with the
Securities Act and the Securities Act Regulations and shall conform in all material respects to the requirements of the Securities Act
and the Securities Act Regulations, and neither the Registration Statement, the Disclosure Package, the Prospectus nor any Issuer Free
Writing Prospectus nor any amendment or supplement thereto shall contain any untrue statement of a material fact or omit to state any
material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they
were made, not misleading.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">4.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Corporate Proceedings</U>. All corporate proceedings and other legal matters incident to the authorization, form and validity of each
of this Agreement, the Public Securities, the Registration Statement, the Disclosure Package, each Issuer Free Writing Prospectus, if
any, and the Prospectus and all other legal matters relating to this Agreement and the transactions contemplated hereby and thereby shall
be reasonably satisfactory in all material respects to Underwriter&rsquo;s Counsel and the Company shall have furnished to such counsel
all documents and information that they may reasonably request to enable them to pass upon such matters.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">4.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Delivery of Agreements</U>. On or before the date of this Agreement, the Company shall have delivered to the Underwriter executed copies
of the Lock-Up Agreements from each of the persons listed in <U>Schedule 2</U> hereto.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">4.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Additional Documents</U>. At the Closing Date and each Option Closing Date, if any, Underwriter&rsquo;s Counsel shall have been furnished
with such documents and opinions as they may require for the purpose of enabling Underwriter&rsquo;s Counsel to deliver an opinion to
the Underwriter, or in order to evidence the accuracy of any of the representations or warranties, or the fulfilment of any of the conditions,
herein contained; and all proceedings taken by the Company in connection with the issuance and sale of the Public Securities as herein
contemplated shall be satisfactory in form and substance to the Underwriter and Underwriter&rsquo;s Counsel. </FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-weight: normal">5.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-weight: normal"><U>Indemnification</U>.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">5.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Indemnification by the Company</U>. The Company shall indemnify and hold harmless the Underwriter, its affiliates and each of its and
their respective directors, officers, members, employees, representatives and agents and each person, if any, who controls the Underwriter
within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act (collectively the &ldquo;</FONT><FONT STYLE="font-style: normal">Underwriter
Indemnified Parties<FONT STYLE="font-weight: normal">,&rdquo; and each an &ldquo;</FONT>Underwriter Indemnified Party<FONT STYLE="font-weight: normal">&rdquo;)
against any loss, claim, damage, expense or liability whatsoever (or any action, investigation or proceeding in respect thereof), to which
such Underwriter Indemnified Party may become subject, under the Securities Act or otherwise, insofar as such loss, claim, damage, expense,
liability, action, investigation or proceeding arises out of or is based upon (A) any untrue statement or alleged untrue statement of
a material fact contained in any Preliminary Prospectus, the Disclosure Package, any Issuer Free Writing Prospectus, any &ldquo;issuer
information&rdquo; filed or required to be filed pursuant to Rule 433(d) of the Securities Act Regulations, any Registration Statement
or the Prospectus, or in any amendment or supplement thereto or document incorporated by reference therein, (B) the omission or alleged
omission to state in any Preliminary Prospectus, the Disclosure Package, any Issuer Free Writing Prospectus, any &ldquo;issuer information&rdquo;
filed or required to be filed pursuant to Rule 433(d) of the Securities Act Regulations, any Registration Statement or the Prospectus,
or in any amendment or supplement thereto or document incorporated by reference therein, a material fact required to be stated therein
or necessary to make the statements therein not misleading or (C) any breach of the representations and warranties of the Company contained
herein or any certificate delivered pursuant to this Agreement or failure of the Company to perform its obligations hereunder or pursuant
to any law, any act or failure to act, or any alleged act or failure to act, by the Company in connection with, or relating in any manner
to, this Agreement, the Public Securities or the Offering, and which is included as part of or referred to in any loss, claim, damage,
expense, liability, action, investigation or proceeding arising out of or based upon matters covered by <U>subclause (A)</U>, <U>(B)</U>
or <U>(C)</U> above of this <U>Section 5.1</U> (provided&nbsp;that the Company shall not be liable in the case of any matter covered by
this <U>subclause (C)</U> to the extent that it is determined in a final judgment by a court of competent jurisdiction that such loss,
claim, damage, expense or liability resulted directly from any such act or failure to act undertaken or omitted to be taken by the Underwriter
through its gross negligence or willful misconduct), and shall reimburse the Underwriter Indemnified Party promptly upon demand for any
legal fees or other expenses reasonably incurred by that Underwriter Indemnified Party in connection with investigating, or preparing
to defend, or defending against, or appearing as a third party witness in respect of, or otherwise incurred in connection with, any such
loss, claim, damage, expense, liability, action, investigation or proceeding, as such fees and expenses are incurred;&nbsp;</FONT></FONT><FONT STYLE="font-weight: normal"><U>provided</U><FONT STYLE="font-style: normal">,
</FONT><U>however</U><FONT STYLE="font-style: normal">,&nbsp;that the Company shall not be liable in any such case to the extent that
any such loss, claim, damage, expense or liability arises out of or is based upon an untrue statement in, or omission from any Preliminary
Prospectus, the Disclosure Package, any Registration Statement or the Prospectus, or any such amendment or supplement thereto, or any
Issuer Free Writing Prospectus made in reliance upon and in conformity with written information furnished to the Company by or on behalf
of the Underwriter specifically for use therein, which information the parties hereto agree is limited to the Underwriter&rsquo;s Information.
This indemnity agreement is not exclusive and will be in addition to any liability, which the Company might otherwise have and shall not
limit any rights or remedies which may otherwise be available at law or in equity to each Underwriter Indemnified Party.</FONT></FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">5.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Indemnification by the Underwriter</U>. The Underwriter shall indemnify and hold harmless the Company, the Company&rsquo;s directors,
its officers who signed the Registration Statement and each person, if any, who controls the Company within the meaning of Section 15
of the Securities Act or Section 20 of the Exchange Act (collectively the &ldquo;Company Indemnified Parties&rdquo; and each a </FONT><FONT STYLE="font-style: normal">&ldquo;Company
Indemnified Party<FONT STYLE="font-weight: normal">&rdquo;) against any loss, claim, damage, expense or liability whatsoever (or any action,
investigation or proceeding in respect thereof), to which such Company Indemnified Party may become subject, under the Securities Act
or otherwise, insofar as such loss, claim, damage, expense, liability, action, investigation or proceeding arises out of or is based upon
(i) any untrue statement of a material fact contained in any Preliminary Prospectus, any Issuer Free Writing Prospectus, any &ldquo;issuer
information&rdquo; filed or required to be filed pursuant to Rule 433(d) of the Securities Act Regulations, any Registration Statement,
the Disclosure Package, or the Prospectus, or in any amendment or supplement thereto, or (ii) the omission to state in any Preliminary
Prospectus, any Issuer Free Writing Prospectus, any &ldquo;issuer information&rdquo; filed or required to be filed pursuant to Rule 433(d)
of the Securities Act Regulations, any Registration Statement, the Disclosure Package, or the Prospectus, or in any amendment or supplement
thereto, a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances
under which they were made, not misleading, but in each case only to the extent that the untrue statement or omission was made in reliance
upon and in conformity with written information furnished to the Company by or on behalf of the Underwriter specifically for use therein,
which information the parties hereto agree is limited to the Underwriter&rsquo;s Information and shall reimburse the Company Indemnified
Parties for any legal or other expenses reasonably incurred by any Company Indemnified Party in connection with investigating or preparing
to defend or defending against or appearing as third party witness in connection with any such loss, claim, damage, liability, action,
investigation or proceeding, as such fees and expenses are incurred. Notwithstanding the provisions of this <U>Section 5.2</U>, in no
event shall any indemnity by the Underwriter under this <U>Section 5.2</U> exceed the total discount and commission received by the Underwriter
in connection with the Offering.</FONT></FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">5.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Procedure</U>. Promptly after receipt by an indemnified party under this <U>Section 5</U> of notice of the commencement of any action,
the indemnified party shall, if a claim in respect thereof is to be made against an indemnifying party under this <U>Section 5</U>, notify
such indemnifying party in writing of the commencement of that action; </FONT><FONT STYLE="font-weight: normal"><U>provided</U><FONT STYLE="font-style: normal">,
</FONT><U>however</U><FONT STYLE="font-style: normal">, that the failure to notify the indemnifying party shall not relieve it from any
liability which it may have under this <U>Section 5</U> except to the extent it has been materially adversely prejudiced by such failure;
and, provided, further, that the failure to notify an indemnifying party shall not relieve it from any liability which it may have to
an indemnified party otherwise than under this <U>Section 5</U>. If any such action shall be brought against an indemnified party, and
it shall notify the indemnifying party thereof, the indemnifying party shall assume the defense of such action with counsel reasonably
satisfactory to the indemnified party (which counsel shall not, except with the written consent of the indemnified party, be counsel to
the indemnifying party). After notice from the indemnifying party to the indemnified party of its assumption of the defense of such action,
except as provided herein, the indemnifying party shall not be liable to the indemnified party under <U>Section 5</U> for any legal or
other expenses subsequently incurred by the indemnified party in connection with the defense of such action other than reasonable costs
of investigation; </FONT><U>provided</U><FONT STYLE="font-style: normal">, </FONT><U>however</U><FONT STYLE="font-style: normal">, that
any indemnified party shall have the right to employ separate counsel in any such action and to participate in the defense of such action
but the fees and expenses of such counsel (other than reasonable costs of investigation) shall be at the expense of such indemnified party
unless (i) the employment thereof has been specifically authorized in writing by the Company in the case of a claim for indemnification
under <U>Section 5.1</U> or the Underwriter in the case of a claim for indemnification under <U>Section 5.2</U>, (ii) such indemnified
party shall have been advised by its counsel that there may be one or more legal defenses available to it which are different from or
additional to those available to the indemnifying party, or (iii) the indemnifying party has failed to assume the defense of such action
and employ counsel reasonably satisfactory to the indemnified party within a reasonable period of time after notice of the commencement
of the action or the indemnifying party does not diligently defend the action after assumption of the defense, in which case, if such
indemnified party notifies the indemnifying party in writing that it elects to employ separate counsel at the expense of the indemnifying
party, the indemnifying party shall not have the right to assume the defense of (or, in the case of a failure to diligently defend the
action after assumption of the defense, to continue to defend) such action on behalf of such indemnified party and the indemnifying party
shall be responsible for legal or other expenses subsequently incurred by such indemnified party in connection with the defense of such
action; </FONT><U>provided</U><FONT STYLE="font-style: normal">, </FONT><U>however</U><FONT STYLE="font-style: normal">, that the indemnifying
party shall not, in connection with any one such action or separate but substantially similar or related actions in the same jurisdiction
arising out of the same general allegations or circumstances, be liable for the reasonable fees and expenses of more than one separate
firm of attorneys at any time any such indemnified party (in addition to any local counsel), which firm shall be designated in writing
by the Underwriter if the indemnified party under this <U>Section 5</U> is an Underwriter Indemnified Party or by the Company if an indemnified
party under this <U>Section 5</U> is a Company Indemnified Party. Subject to this <U>Section 5.3</U>, the amount payable by an indemnifying
party under <U>Section 5</U> shall include, but not be limited to, (x) reasonable legal fees and expenses of counsel to the indemnified
party and any other expenses in investigating, or preparing to defend or defending against, or appearing as a third party witness in respect
of, or otherwise incurred in connection with, any action, investigation, proceeding or claim, and (y) all amounts paid in settlement of
any of the foregoing. No indemnifying party shall, without the prior written consent of the indemnified parties, settle or compromise
or consent to the entry of judgment with respect to any pending or threatened action or any claim whatsoever, in respect of which indemnification
or contribution could be sought under this <U>Section 5</U> (whether or not the indemnified parties are actual or potential parties thereto),
unless such settlement, compromise or consent (i) includes an unconditional release of each indemnified party in form and substance reasonably
satisfactory to such indemnified party from all liability arising out of such action or claim and (ii) does not include a statement as
to or an admission of fault, culpability or a failure to act by or on behalf of any indemnified party. Subject to the provisions of the
following sentence, no indemnifying party shall be liable for settlement of any pending or threatened action or any claim whatsoever that
is effected without its written consent (which consent shall not be unreasonably withheld or delayed), but if settled with its written
consent, if its consent has been unreasonably withheld or delayed or if there be a judgment for the plaintiff in any such matter, the
indemnifying party agrees to indemnify and hold harmless any indemnified party from and against any loss or liability by reason of such
settlement or judgment. In addition, if at any time an indemnified party shall have requested that an indemnifying party reimburse the
indemnified party for fees and expenses of counsel, such indemnifying party agrees that it shall be liable for any settlement of the nature
contemplated herein effected without its written consent if (i) such settlement is entered into more than forty-five (45) days after receipt
by such indemnifying party of the request for reimbursement, (ii) such indemnifying party shall have received notice of the terms of such
settlement at least thirty (30) days prior to such settlement being entered into and (iii) such indemnifying party shall not have reimbursed
such indemnified party in accordance with such request prior to the date of such settlement.</FONT></FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">5.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Contribution</U>. If the indemnification provided for in this <U>Section 5</U> is unavailable or insufficient to hold harmless an indemnified
party under <U>Section 5.1</U> or <U>Section 5.2</U>, then each indemnifying party shall, in lieu of indemnifying such indemnified party,
contribute to the amount paid, payable or otherwise incurred by such indemnified party as a result of such loss, claim, damage, expense
or liability (or any action, investigation or proceeding in respect thereof), as incurred, (i) in such proportion as shall be appropriate
to reflect the relative benefits received by the Company on the one hand and the Underwriter on the other hand from the Offering, or (ii)
if the allocation provided by <U>clause (i)</U> of this <U>Section 5.4</U> is not permitted by applicable law, in such proportion as is
appropriate to reflect not only the relative benefits referred to in <U>clause (i)</U> of this <U>Section 5.4</U> but also the relative
fault of the Company on the one hand and the Underwriter on the other with respect to the statements, omissions, acts or failures to act
which resulted in such loss, claim, damage, expense or liability (or any action, investigation or proceeding in respect thereof) as well
as any other relevant equitable considerations. The relative benefits received by the Company on the one hand and the Underwriter on the
other with respect to such offering shall be deemed to be in the same proportion as the total proceeds from the Offering purchased under
this Agreement (before deducting expenses) received by the Company bear to the total underwriting discount and commissions received by
the Underwriter in connection with the Offering, in each case as set forth in the table on the cover page of the Prospectus. The relative
fault of the Company on the one hand and the Underwriter on the other shall be determined by reference to, among other things, whether
the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information
supplied by the Company on the one hand or the Underwriter on the other, the intent of the parties and their relative knowledge, access
to information and opportunity to correct or prevent such untrue statement, omission, act or failure to act; provided that the parties
hereto agree that the written information furnished to the Company by or on behalf of the Underwriter for use in any Preliminary Prospectus,
any Registration Statement, the Disclosure Package or the Prospectus, or in any amendment or supplement thereto, consists solely of the
Underwriter&rsquo;s Information. The Company and the Underwriter agree that it would not be just and equitable if contributions pursuant
to this <U>Section 5.4</U> be determined by pro rata allocation or by any other method of allocation that does not take into account the
equitable considerations referred to herein. The amount paid or payable by an indemnified party as a result of the loss, claim, damage,
expense, liability, action, investigation or proceeding referred to above in this <U>Section 5.4</U> shall be deemed to include, for purposes
of this <U>Section 5.4</U>, any legal or other expenses reasonably incurred by such indemnified party in connection with investigating,
preparing to defend or defending against or appearing as a third party witness in respect of, or otherwise incurred in connection with,
any such loss, claim, damage, expense, liability, action, investigation or proceeding. Notwithstanding the provisions of this <U>Section
5.4</U>, the Underwriter shall not be required to contribute any amount in excess of the total discount and commission received by the
Underwriter in connection with the Offering less the amount of any damages which the Underwriter has otherwise paid or become liable to
pay by reason of any untrue or alleged untrue statement, omission or alleged omission, act or alleged act or failure to act or alleged
failure to act. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be
entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. The Underwriter&rsquo;s obligation to
contribute as provided in this <U>Section 5.4</U> are several and in proportion to their respective underwriting obligation, and not joint.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-weight: normal">6.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-weight: normal"><U>Additional Covenants</U>.</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">6.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Board Composition and Board Designations</U>. The Company shall ensure that: (i)&nbsp;the qualifications of the persons serving as
members of the Board of Directors and the overall composition of the Board of Directors comply with the Sarbanes-Oxley Act, the Exchange
Act and the listing rules of the NasdaqCM or any other national securities exchange, as the case may be, in the event the Company seeks
to have its Common Stock listed on another exchange or quoted on an automated quotation system, subject to any applicable cure period,
and (ii)&nbsp;if applicable, at least one member of the Audit Committee of the Board of Directors qualifies as an &ldquo;audit committee
financial expert,&rdquo; as such term is defined under Regulation S-K and the listing rules of the NasdaqCM.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">6.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Prohibition on Press Releases and Public Announcements</U>. Except with respect to the previously announced first quarter conference
call to be held on June 2, 2022 and the 2022 annual meeting of shareholders to be held on June 6, 2022, prior to the last Option Closing
Date, if any, the Company shall not issue any press release or other communication directly or indirectly or hold any press conference
with respect to the Company, its condition, financial or otherwise, or earnings, business affairs or business prospects (except for routine
oral marketing communications in the ordinary course of business and consistent with the past practices of the Company and of which the
Underwriter is notified), without the prior written consent of the Underwriter (not to be withheld unreasonably), unless in the judgment
of the Company and its counsel, and after notification to the Underwriter, such press release or communication is required by law or applicable
NasdaqCM rules.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-weight: normal">7.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-weight: normal"><U>Effective Date of this
Agreement and Termination Thereof</U>.</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">7.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Effective Date</U>. This Agreement shall become effective when both the Company and the Underwriter have executed the same and delivered
counterparts of such signatures to the other party.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">7.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Termination</U>. The Underwriter shall have the right to terminate this Agreement at any time prior to the Closing Date, (i)&nbsp;if
any domestic or international event or act or occurrence has materially disrupted, or in your opinion will in the immediate future materially
disrupt, general securities markets in the United States; or (ii)&nbsp;if trading on the New York Stock Exchange or Nasdaq Stock Market
LLC shall have been suspended or materially limited, or minimum or maximum prices for trading shall have been fixed, or maximum ranges
for prices for securities shall have been required by FINRA or by order of the Commission or any other government authority having jurisdiction;
or (iii)&nbsp;if the United States shall have become involved in a new war or an increase in major hostilities; or (iv)&nbsp;if a banking
moratorium has been declared by a New York State or federal authority; or (v)&nbsp;if a moratorium on foreign exchange trading has been
declared which materially adversely impacts the United States securities markets; or (vi)&nbsp;if the Company shall have sustained a material
loss by fire, flood, accident, hurricane, earthquake, theft, sabotage or other calamity or malicious act which, whether or not such loss
shall have been insured, will, in your opinion, make it inadvisable to proceed with the delivery of the Firm Shares or the Additional
Shares; or (vii)&nbsp;if the Company is in material breach of any of its representations, warranties or covenants hereunder; or (viii)&nbsp;if
the Underwriter shall have become aware after the date hereof of such a material adverse change in the conditions or prospects of the
Company, or such adverse material change in general market conditions as in the Underwriter&rsquo;s judgment would make it impracticable
to proceed with the offering, sale and/or delivery of the Public Securities or to enforce contracts made by the Underwriter for the sale
of the Public Securities.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">7.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Expenses</U>. Notwithstanding anything to the contrary in this Agreement, in the event that this Agreement shall not be carried out
for any reason whatsoever, within the time specified herein or any extensions thereof pursuant to the terms herein, the Company shall
be obligated to pay to the Underwriter its reasonable accountable out-of-pocket expenses related to the transactions contemplated herein
then due and payable (including the fees and disbursements of Underwriter&rsquo;s Counsel) up to $30,000 and upon demand the Company shall
pay the full amount thereof to the Underwriter on behalf of the Underwriter; </FONT><FONT STYLE="font-weight: normal">provided, however,
<FONT STYLE="font-style: normal">that such expense cap in no way limits or impairs the indemnification and contribution provisions of
this Agreement. Notwithstanding the foregoing, any advance received by the Underwriter will be reimbursed to the Company to the extent
not actually incurred in compliance with FINRA Rule 5110(f)(2)(C).</FONT></FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">7.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Survival of Indemnification</U>. Notwithstanding any contrary provision contained in this Agreement, any election hereunder or any
termination of this Agreement, and whether or not this Agreement is otherwise carried out, the provisions of <U>Section 5</U> shall remain
in full force and effect and shall not be in any way affected by, such election or termination or failure to carry out the terms of this
Agreement or any part hereof.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">7.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Representations, Warranties, Agreements to Survive</U>. All representations, warranties and agreements contained in this Agreement
or in certificates of officers of the Company submitted pursuant hereto, shall remain operative and in full force and effect regardless
of (i)&nbsp;any investigation made by or on behalf of the Underwriter or its affiliates or selling agents, any person controlling the
Underwriter, its officers or directors or any person controlling the Company or (ii)&nbsp;delivery of and payment for the Public Securities.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-weight: normal">8.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-weight: normal"><U>Miscellaneous</U>.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">8.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Notices</U>. All communications hereunder, except as herein otherwise specifically provided, shall be in writing and shall be mailed
(registered or certified mail, return receipt requested), personally delivered or sent by facsimile transmission and confirmed and shall
be deemed given when so delivered or faxed and confirmed or if mailed, two (2) days after such mailing.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If to the Underwriter:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">Newbridge Securities Corporation</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">1200 North Federal Highway</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">Boca Raton, Florida 33432</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 6%">&nbsp;</TD>
    <TD STYLE="width: 8%">Attn:</TD>
    <TD STYLE="width: 43%">Chad D. Champion, Senior Managing Director &ndash; Head of Investment Banking and Capital Markets</TD>
    <TD STYLE="width: 43%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Email:</TD>
    <TD>cchampion@newbridgesecurities.com</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Tel. No:</TD>
    <TD>(561) 453-2270</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">with a copy (which shall not constitute notice) to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">McGuireWoods LLP</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">1251 Avenue of the Americas, 20th Floor</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">New York, NY 10020</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 6%">&nbsp;</TD>
    <TD STYLE="width: 8%">Attn:</TD>
    <TD STYLE="width: 43%">Stephen Older, Esq.</TD>
    <TD STYLE="width: 43%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>David S. Wolpa, Esq.</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Email:</TD>
    <TD>solder@mcguirewoods.com</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>dwolpa@mcguirewoods.com</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">If to the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">ClearSign Technologies Corporation</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">8023 E. 63rd Place, Suite 101</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">Tulsa, Oklahoma</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 6%">&nbsp;</TD>
    <TD STYLE="width: 8%">Attn:</TD>
    <TD STYLE="width: 43%">Colin James Deller, Chief Executive Officer</TD>
    <TD STYLE="width: 43%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Brent Hinds, Vice President and Controller</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Email:</TD>
    <TD>jim.deller@clearsign.com</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>brent.hinds@clearsign.com</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Tel. No:</TD>
    <TD>(206) 673-4848</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">with a copy (which shall not constitute notice) to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">Mitchell Silberberg &amp; Knupp LLP</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">437 Madison Avenue, 25th Floor</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">New York, New York 10022</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 6%">&nbsp;</TD>
    <TD STYLE="width: 8%">Attn:</TD>
    <TD STYLE="width: 43%">Blake Baron</TD>
    <TD STYLE="width: 43%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Email:</TD>
    <TD>bjb@msk.com</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Tel. No:</TD>
    <TD>(917) 546-7709</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">8.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Headings</U>. The headings contained herein are for the sole purpose of convenience of reference, and shall not in any way limit or
affect the meaning or interpretation of any of the terms or provisions of this Agreement.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">8.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Absence of Fiduciary Relationship</U>. The Company acknowledges and agrees that:</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 103.7pt">(i) the Underwriter&rsquo;s
responsibility to the Company is solely contractual in nature, the Underwriter has been retained solely to act as an underwriter in connection
with the Offering and no fiduciary, advisory or agency relationship between the Company and the Underwriter has been created in respect
of any of the transactions contemplated by this Agreement, irrespective of whether either the Underwriter has advised or is advising the
Company on other matters;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 103.7pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 103.7pt">(ii) the price of the Public
Securities set forth in this Agreement was established by the Company following discussions and arms-length negotiations with the Underwriter,
and the Company is capable of evaluating and understanding, and understands and accepts, the terms, risks and conditions of the transactions
contemplated by this Agreement; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 103.7pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 103.7pt">(iii) it has been advised
that the Underwriter and its respective affiliates are engaged in a broad range of transactions which may involve interests that differ
from those of the Company and that the Underwriter has no obligation to disclose such interests and transactions to the Company by virtue
of any fiduciary, advisory or agency relationship.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 103.7pt">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">8.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Research Analyst Independence</U>. The Company acknowledges that the Underwriter&rsquo;s research analysts and research departments
are required to be independent from its investment banking division and are subject to certain regulations and internal policies, and
that the Underwriter&rsquo;s research analysts may hold views and make statements or investment recommendations and/or publish research
reports with respect to the Company and/or the offering that differ from the views of their investment banking division. The Company acknowledges
that the Underwriter is a full service securities firm and as such from time to time, subject to applicable securities laws, rules and
regulations, may effect transactions for its own account or the account of its customers and hold long or short positions in debt or equity
securities of the Company; provided, however, that nothing in this <U>Section 8.4</U> shall relieve the Underwriter of any responsibility
or liability it may otherwise bear in connection with activities in violation of applicable securities laws, rules or regulations.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">8.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendment</U>. This Agreement may only be amended by a written instrument executed by each of the parties hereto.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">8.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Entire Agreement</U>. This Agreement (together with the other agreements and documents being delivered pursuant to or in connection
with this Agreement) constitutes the entire agreement of the parties hereto with respect to the subject matter hereof and thereof, and
supersedes all prior agreements and understandings of the parties, oral and written, with respect to the subject matter hereof. </FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">8.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Binding Effect</U>. This Agreement shall inure solely to the benefit of and shall be binding upon the Underwriter, the Company and
the controlling persons, directors and officers referred to in <U>Section 5</U>, and their respective successors, legal representative,
heirs and assigns, and no other person shall have or be construed to have any legal or equitable right, remedy or claim under or in respect
of or by virtue of this Agreement or any provisions herein contained. The term &ldquo;successors and assigns&rdquo; shall not include
a purchaser, in its capacity as such, of securities from the Underwriter.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">8.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Governing Law; Consent to Jurisdiction; Trial by Jury</U>. This Agreement shall be governed by and construed and enforced in accordance
with the laws of the State of Delaware, without giving effect to conflict of laws principles thereof. The Company hereby agrees that any
action, proceeding or claim against it arising out of, or relating in any way to this Agreement shall be brought and enforced in state
and federal courts located in the Borough of Manhattan in the City of New York, and irrevocably submits to such jurisdiction, which jurisdiction
shall be exclusive. The Company hereby waives any objection to such exclusive jurisdiction and that such courts represent an inconvenient
forum. Any such process or summons to be served upon the Company may be served by transmitting a copy thereof by registered or certified
mail, return receipt requested, postage prepaid, addressed to it at the address set forth in <U>Section 9.1</U>. Such mailing shall be
deemed personal service and shall be legal and binding upon the Company in any action, proceeding or claim. The Company agrees that the
prevailing party(ies) in any such action shall be entitled to recover from the other party(ies) all of its reasonable attorneys&rsquo;
fees and expenses relating to such action or proceeding and/or incurred in connection with the preparation therefor. The Company (on its
behalf and, to the extent permitted by applicable law, on behalf of its shareholders and affiliates) and the Underwriter hereby irrevocably
waives, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or
relating to this Agreement or the transactions contemplated hereby.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">8.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Execution in Counterparts</U>. This Agreement may be executed in one or more counterparts, and by the different parties hereto in separate
counterparts, each of which shall be deemed to be an original, but all of which taken together shall constitute one and the same agreement,
and shall become effective when one or more counterparts has been signed by each of the parties hereto and delivered to each of the other
parties hereto. Delivery of a signed counterpart of this Agreement by facsimile or email/pdf transmission shall constitute valid and sufficient
delivery thereof.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">8.10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Waiver, etc</U>. The failure of any of the parties hereto to at any time enforce any of the provisions of this Agreement shall not
be deemed or construed to be a waiver of any such provision, nor to in any way effect the validity of this Agreement or any provision
hereof or the right of any of the parties hereto to thereafter enforce each and every provision of this Agreement. No waiver of any breach,
non-compliance or non-fulfillment of any of the provisions of this Agreement shall be effective unless set forth in a written instrument
executed by the party or parties against whom or which enforcement of such waiver is sought; and no waiver of any such breach, non-compliance
or non-fulfillment shall be construed or deemed to be a waiver of any other or subsequent breach, non-compliance or non-fulfillment.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">[Signature Page Follows]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence -->-</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">If
the foregoing correctly sets forth the understanding between the Underwriter and the Company, please so indicate in the space provided
below for that purpose, whereupon this letter shall constitute a binding agreement between us.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">Very truly yours,</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 25%">&nbsp;</TD>
    <TD STYLE="width: 25%">&nbsp;</TD>
    <TD STYLE="width: 6%">&nbsp;</TD>
    <TD STYLE="width: 44%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">CLEARSIGN TECHNOLOGIES CORPORATION</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid">/s/ Colin James Deller</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Colin James Deller, Chief Executive Officer</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">Confirmed as of the date first written above mentioned:</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 6%">&nbsp;</TD>
    <TD STYLE="width: 44%">&nbsp;</TD>
    <TD STYLE="width: 25%">&nbsp;</TD>
    <TD STYLE="width: 25%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">NEWBRIDGE SECURITIES CORPORATION</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid">/s/ Chad D. Champion</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Name:</TD>
    <TD>Chad D. Champion</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Title:</TD>
    <TD>Senior Managing Director, Head of Investment Banking and Capital Markets</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-variant: small-caps">[Signature Page]</FONT></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-variant: small-caps">ClearSign Technologies Corporation &ndash; Underwriting Agreement</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>SCHEDULE 1-A</U></B><U><BR>
<BR>
</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>Pricing Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Number of Firm Shares: <B>3,640,000</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Number of Additional Shares: <B>546,000</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Public Offering Price per Share: $<B>1.11</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Underwriting Discount per Share: $<B>0.0666</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Proceeds to Company per Share (before expenses): $<B>1.0434</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Sch. 1-A-<FONT STYLE="font-family: Times New Roman, Times, Serif">1</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>SCHEDULE 1-B</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Issuer General Use Free Writing Prospectuses</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">None.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Sch. 1-B-<FONT STYLE="font-family: Times New Roman, Times, Serif">1</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>SCHEDULE 2</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>List of Lock-Up Parties</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Colin James Deller</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Brent Hinds</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Robert T. Hoffman</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Judith S. Schrecker</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Susanne L. Meline</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Bruce A. Pate</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">GPclirSPV LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">clirSPV LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 37 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Sch. 2-<FONT STYLE="font-family: Times New Roman, Times, Serif">1</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>EXHIBIT A</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Form of Lock-Up Agreement<BR>
<BR>
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">May ___, 2022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Newbridge Securities Corporation</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1200 North Federal Highway</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Boca Raton, Florida 33432</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned understands
that Newbridge Securities Corporation (the &ldquo;<B>Underwriter</B>&rdquo;) proposes to enter into an Underwriting Agreement (the &ldquo;<B>Underwriting
Agreement</B>&rdquo;) with ClearSign Technologies Corporation, a Washington corporation (the &ldquo;<B>Company</B>&rdquo;), providing
for the public offering (the &ldquo;<B>Public Offering</B>&rdquo;) of shares of Common Stock, par value $0.0001 per share, of the Company
(the &ldquo;<B>Common Stock</B>&rdquo; or the &ldquo;<B>Securities</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To induce the Underwriter
to continue its efforts in connection with the Public Offering, the undersigned hereby agrees that, without the prior written consent
of the Underwriter, the undersigned will not, during the period commencing on the date hereof and ending ninety (90) days after the date
of the final prospectus (the &ldquo;<B>Prospectus</B>&rdquo;) relating to the Public Offering (the &ldquo;<B>Lock-Up Period</B>&rdquo;),
(1) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any
option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any Common Stock or any securities
convertible into or exercisable or exchangeable for Common Stock, whether now owned or hereafter acquired by the undersigned or with respect
to which the undersigned has or hereafter acquires the power of disposition (collectively, the &ldquo;<B>Lock-Up Securities</B>&rdquo;);
(2) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership
of Lock-Up Securities, whether any such transaction described in clause (1) or (2) above is to be settled by delivery of Lock-Up Securities,
in cash or otherwise; (3) make any demand for or exercise any right with respect to the registration of any Lock-Up Securities, except
as set forth in any agreements with the Company prior to the date hereof; or (4) publicly disclose the intention to make any offer, sale,
pledge or disposition, or to enter into any transaction, swap, hedge or other arrangement relating to any Lock-Up Securities. Notwithstanding
the foregoing, and subject to the conditions below, the undersigned may transfer Lock-Up Securities without the prior written consent
of the Underwriter in connection with (a) transactions relating to Lock-Up Securities acquired in open market transactions after the completion
of the Public Offering; <I>provided</I> that no filing under Section&nbsp;13 or Section 16(a) of the Securities Exchange Act of 1934,
as amended (the &ldquo;<B>Exchange Act</B>&rdquo;), shall be required or shall be voluntarily made during the Lock-Up Period in connection
with subsequent sales of Lock-Up Securities acquired in such open market transactions; (b) transfers of Lock-Up Securities as a <I>bona
fide</I> gift, by will or intestacy or to a family member or trust for the benefit of a family member (for purposes of this lock-up agreement,
 &ldquo;family member&rdquo; means any relationship by blood, marriage or adoption, not more remote than first cousin); (c) transfers or
dispositions by operation of law, such as pursuant to a qualified domestic order, divorce settlement, divorce decree, separation agreement
or other court order; (d) transfers of Lock-Up Securities to a charity or educational institution; (e) if the undersigned, or a family
member, directly or indirectly, controls a corporation, partnership, limited liability company or other business entity, any transfers
of Lock-Up Securities to such business entity or to any shareholder, partner or member of, or owner of similar equity interests in, the
undersigned, as the case may be; (f) the sales of Common Stock to cover the payment of the exercise prices or the payment of taxes associated
with the exercise or vesting of equity awards under any equity compensation plan of the Company; (g) if the undersigned is a corporation,
partnership, limited liability company, trust or other business entity (1) transfers to another corporation, partnership, limited liability
company, trust or other business entity that is a direct or indirect affiliate (as defined in Rule 405 promulgated under the Securities
Act of 1933, as amended) of the undersigned or (2) distributions of shares of Common Stock or any security convertible into or exercisable
for Common Stock to partners, members, stockholders, subsidiaries or affiliates of the undersigned; (h) if the undersigned is a trust,
transfers to the trustee or beneficiary of such trust; (i) transfers pursuant to the Underwriting Agreement; (j) transfers in connection
with a change of control of the Company; or (k) transfers pursuant to contract-based buy-backs by the Company, <I>provided</I> that in
the case of any transfer pursuant to the foregoing clauses&nbsp;(b), (c), (d), (e), (f), (g) or (h), it shall be a condition that (i)
each transferee shall sign and deliver to the Underwriter a lock-up agreement substantially in the form of this lock-up agreement; (ii)
the transferee/donee agrees to be bound by the terms of this lock-up agreement (including, without limitation, the restrictions set forth
in the preceding sentence) to the same extent as if the transferee/donee were a party hereto; and (iii) no filing under Section&nbsp;16(a)
of the Exchange Act shall be required or shall be voluntarily made prior to the expiration of the Lock-Up Period, except for a Form 5.
The undersigned also agrees and consents to the entry of stop transfer instructions with the Company&rsquo;s transfer agent and registrar
against the transfer of the undersigned&rsquo;s Lock-Up Securities except in compliance with this lock-up agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 38; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%"></TD><TD STYLE="width: 34%; text-align: center">Ex. A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, the foregoing
restrictions shall not apply to (i) the exercise or vesting of stock options or other equity awards granted pursuant to an agreement with
the Company or the Company&rsquo;s equity incentive plans or to the exercise, exchange or conversion by the undersigned of any other securities
exercisable or exchangeable for or convertible into Common Stock, as applicable; provided that it shall apply to any of the undersigned&rsquo;s
Common Stock issued upon such exercise, exchange or conversion, (ii) the conversion or exercise of convertible debt or warrants; provided
that it shall apply to any of the undersigned&rsquo;s Common Stock issued upon such conversion or exercise, or (iii) the establishment
of any new plan (a &ldquo;<B>Plan</B>&rdquo;) that satisfies all of the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act;
provided that no sales of the undersigned&rsquo;s Securities shall be made pursuant to such new Plan prior to the expiration of the Lock-Up
Period (as such may have been extended pursuant to the provisions hereof).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the undersigned is an officer
or director of the Company, (i) the undersigned agrees that the foregoing restrictions shall be equally applicable to any issuer-directed
or &ldquo;friends and family&rdquo; Common Stock that the undersigned may purchase in the Public Offering; (ii) the Underwriter agrees
that, at least three (3) Business Days (as that term is defined in the Underwriting Agreement) before the effective date of any release
or waiver of the foregoing restrictions in connection with a transfer of Lock-Up Securities, the Underwriter will notify the Company of
the impending release or waiver; and (iii) the Company has agreed in the Underwriting Agreement to announce the impending release or waiver
by press release through a major news service at least two (2) Business Days before the effective date of the release or waiver, if required
by the terms of the Underwriting Agreement. Any release or waiver granted by the Underwriter hereunder to any such officer or director
shall only be effective two (2) Business Days after the publication date of such press release. The provisions of this paragraph will
not apply if (a) the release or waiver is effected solely to permit a transfer of Lock-Up Securities not for consideration and (b) the
transferee has agreed in writing to be bound by the same terms described in this lock-up agreement to the extent and for the duration
that such terms remain in effect at the time of such transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned understands
that the Company and the Underwriter are relying upon this lock-up agreement in proceeding toward consummation of the Public Offering.
The undersigned further understands that this lock-up agreement is irrevocable and shall be binding upon the undersigned&rsquo;s heirs,
legal representative, successors and assigns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned understands
that, if the Underwriting Agreement is not executed by June 30, 2022, or if the Underwriting Agreement (other than the provisions thereof
which survive termination) shall terminate or be terminated prior to payment for and delivery of the Securities to be sold thereunder,
then this lock-up agreement shall be void and of no further force or effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 39 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Ex. A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Whether or not the Public
Offering actually occurs depends on a number of factors, including market conditions. Any Public Offering will only be made pursuant
to an Underwriting Agreement, the terms of which are subject to negotiation between the Company and the Underwriter.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">Very truly yours,</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 25%">&nbsp;</TD>
    <TD STYLE="width: 25%">&nbsp;</TD>
    <TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="width: 40%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">(Name - Please Print)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">(Signature)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">(Name of Signatory, in the case of entities - Please Print)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(Title of Signatory, in the case of entities - Please Print)</P>

</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Address:</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 40 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Ex. A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>&nbsp;</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>EXHIBIT B</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Form of Press Release</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>CLEARSIGN TECHNOLOGIES CORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><BR>
[Date]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ClearSign Technologies Corporation (the &ldquo;Company&rdquo;)
announced today that Newbridge Securities Corporation acting as Underwriter for the Company&rsquo;s recent public offering of&nbsp;____
shares of the Company&rsquo;s Common Stock, is [waiving] [releasing] a lock-up restriction with respect to _________&nbsp; shares of the
Company&rsquo;s Common Stock held by [certain officers or directors] [an officer or director] of the Company.&nbsp; The [waiver] [release]
will take effect on&nbsp; _________, 20___, and the shares may be sold on or after such date.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>This press release is not an offer or sale
of the securities in the United States or in any other jurisdiction where such offer or sale is prohibited, and such securities may not
be offered or sold in the United States absent registration or an exemption from registration under the Securities Act of 1933, as amended.</B></P>
<P STYLE="margin: 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="margin: 0; text-align: left"><B></B></P>

<!-- Field: Page; Sequence: 41; Options: NewSection Last; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Ex. B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; text-align: left"><B>&nbsp;</B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>tm2217097d1_ex5-1.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 5.1</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt"><IMG SRC="image_004.jpg" ALT="" STYLE="height: 27pt; width: 82.5pt"></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 51%">
    <P STYLE="font: small-caps 14pt Times New Roman, Times, Serif; margin: 0pt 0">Mitchell Silberberg <FONT STYLE="font-family: Times New Roman, Times, Serif">&amp;</FONT>
    Knupp llp</P>
    <P STYLE="font: small-caps 10pt Times New Roman, Times, Serif; margin: 0pt 0">A Law Partnership Including Professional Corporations</P></TD>
    <TD STYLE="width: 49%; padding-right: 2.15pt; padding-left: 2.15pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">May 31, 2022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; padding-right: 5.75pt; padding-bottom: 0.15in">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Board of Directors</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ClearSign Technologies Corporation</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">8023 East 63<SUP>rd</SUP> Place, Suite 101</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Tulsa, Oklahoma 74133</P></TD></TR>
  </TABLE>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">Re:</TD><TD STYLE="border-bottom: Black 1pt solid">ClearSign Technologies Corporation &ndash; <I>Registration Statement on
                                            Form S-3 (333-232402)</I></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have acted as counsel to ClearSign Technologies
Corporation, a Washington corporation (the &ldquo;Company&rdquo;), in connection with its filing of (i) a Registration Statement on Form
S-3 (Registration No. 333-232402) under the Securities Act of 1933, as amended (the &ldquo;Act&rdquo;), with the Securities and Exchange
Commission (the &ldquo;Commission&rdquo;) (the &ldquo;Registration Statement&rdquo;), (ii) the base prospectus, dated as of July 12, 2019
(the &ldquo;Base Prospectus&rdquo;), included in the Registration Statement and (iii) the prospectus supplement, dated as of May 27, 2022
(the &ldquo;Prospectus Supplement&rdquo; and together with the Base Prospectus as supplemented from time to time by one or more prospectus
supplements, the &ldquo;Prospectus&rdquo;), filed with the Commission on May 27, 2022 by the Company, pursuant to Rule 424 promulgated
under the Act. The Prospectus relates to the public offering of an aggregate of 3,640,000 shares (the &ldquo;Firm Shares&rdquo;) of the
Company&rsquo;s common stock, $0.0001 par value, which includes 546,000 additional shares (the &ldquo;Additional Shares&rdquo; and together
with the Firm Shares, the &ldquo;Public Securities&rdquo;) of the Company&rsquo;s common stock that may be issued upon the exercise of
the underwriter&rsquo;s over-allotment option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Shares are being sold pursuant to an underwriting
agreement, dated as of May 27, 2022, between Newbridge Securities Corporation, as the underwriter, and the Company (the &ldquo;Underwriting
Agreement&rdquo;). This opinion is being furnished in connection with the requirements of Item 601(b)(5) of Regulation S-K under the Act,
and no opinion is expressed herein as to any matter pertaining to the contents of the Registration Statement or the Prospectus, other
than as expressly stated herein with respect to the issuance of the Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have examined and relied
upon such records, documents, certificates and other instruments as in our judgment are necessary or appropriate to enable us to render
the opinions expressed below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The opinions expressed herein are limited solely
to currently applicable federal securities laws of the United States and otherwise are based on our review of the Washington Business
Corporation Act. We express no opinion as to the effect on the matters covered by this letter of the laws of any other jurisdiction. This
opinion is limited to the specific issues addressed herein, and no opinion may be inferred or implied beyond that expressly stated herein.
This opinion speaks only as of the date hereof and we assume no obligation to revise or supplement this opinion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We assume the legal capacity of all natural persons,
the genuineness of all signatures appearing on the documents examined by us, the authenticity and completeness of all documents submitted
to us as originals, and the conformity to the originals of all documents submitted to us as certified, notarized, conformed or photostatic
copies, or facsimiles. With respect to all matters of fact we have relied entirely upon the representations of the parties set forth in
the documents we reviewed, and representations and certifications of officers of the Company we may obtain from the Company, and have
assumed, with your permission and without independent inquiry or investigation, the accuracy of those representations and certificates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">When an opinion or other statement set forth herein
is given to our knowledge, with reference to matters of which we are aware or that are known to us, or with a similar qualification, the
relevant knowledge or awareness is limited to the actual knowledge or awareness of the individual lawyers in this firm who have participated
directly in the specific transactions to which this opinion letter relates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Subject to the limitations set forth herein, we
have made such examination of law as we have deemed necessary for the purposes of this opinion letter. We express no opinion as to the
 &ldquo;blue sky&rdquo; laws and regulations of any jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Based and relying upon and subject to the foregoing,
we are of the opinion that the Shares have been duly authorized for issuance, and when issued against payment therefor pursuant to the
terms of the Underwriting Agreement, will be validly issued, fully paid and non-assessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We hereby consent to the filing of this opinion
as an exhibit to the Registration Statement. In giving this consent, we do not admit that we are within the category of persons whose
consent is required under Section 7 of the Securities Act of 1933, as amended, or the Rules and Regulations of the Commission promulgated
thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">Very truly yours,</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 40%">&nbsp;</TD>
    <TD STYLE="width: 10%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">/s/ Mitchell Silberberg &amp; Knupp LLP</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">MITCHELL SILBERBERG &amp; KNUPP LLP</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
<P STYLE="margin: 0; text-align: left"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; text-align: left"><B>&nbsp;</B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>4
<FILENAME>tm2217097d1_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><B>Exhibit 10.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 198.85pt 0pt 200.15pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 198.85pt 0pt 200.15pt; text-align: center"><B>clirSPV LLC</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 198.85pt 0pt 201.4pt; text-align: center">May 26, 2022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.65pt">Board of Directors</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.85pt">ClearSign Technologies Corporation</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.75in 0pt 6.85pt; text-indent: 36.25pt">Re: Waiver of Notice Requirement
and Participation Right</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.75in 0pt 6.85pt; text-indent: 36.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.75in 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.1pt; text-indent: 37pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.1pt; text-indent: 37pt">Pursuant to Section 2 of Appendix IV of
that certain Stock Purchase Agreement (the &ldquo;Agreement&rdquo;) entered into on July 12, 2018 between ClearSign Technologies Corporation
(the &ldquo;Company&rdquo;) and clirSPV LLC (the &ldquo;Investor&rdquo;), the Investor has a right to participate, on terms and conditions
no different from those offered to other purchasers, its pro rata portion of any new Equity Securities, other than those securities defined
in the Agreement as Excluded Securities, that the Company may from time to time propose to issue or sell for the purpose of raising capital
(the &ldquo;Participation Right&rdquo;). Terms not otherwise defined herein shall have the meanings as assigned to them in the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8pt 0pt 6.45pt; text-indent: 36.25pt">Pursuant to subsection b. of Section
2 of Appendix IV of the Agreement, the Company agreed to give the Investor written notice (the &lsquo;&lsquo;Notice&rdquo;) of any proposed
issuance or sale of new equity securities (the &ldquo;Offering&rdquo;) within five business days following any meeting of the Board at
which the Offering is approved (the &ldquo;Notice Requirement&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.45pt 0pt 5.9pt; text-indent: 36.8pt">The Investor is willing to sign
a waiver of the Company&rsquo;s obligation to comply with the Notice Requirement and modify its Participation Right but wants an extension
of the Participation Right. The Company is willing to extend the Participation Right to a later date, but no later than June 30, 2027
(such date, the &ldquo;Final Expiration Date&rdquo;), to which holders of two-thirds of the units of the Investor agree to extend the
period beyond July 18, 2023 in which they have no right to force a redemption of their interests in the Investor. The Investor believes
that such agreement will enable it to maintain the holdings of the Investor thus lending stability and greater certainty to the stockholder
base of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.45pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.45pt 0pt 5.9pt; text-indent: 36.8pt">For good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the Investor hereby waives for the duration of the Participation Right (i)
the Notice Requirement, including the delivery of an Issuance Notice, as those relate to any future registered offering of New Securities
(other than any Excluded Securities), including the proposed offering through Newbridge Securities Corporation on or around May 27, 2022,
made pursuant to a registration statement on Form S-1 or Form S-3, including any related concurrent private placement (a &ldquo;Future
Offering&rdquo;), and (ii) the requirement that the proposed issuance date be at least 20 days from the date of such notice for a Future
Offering (clauses (i) and (ii) collectively, the &ldquo;Waiver&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.45pt 0pt 5.9pt; text-indent: 36.8pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.4pt 0pt 6.05pt; text-indent: 29.95pt">In exchange for the Waiver, the
Company and the Investor agree that the Participation Right is modified, such that, on the date that the number of new Equity Securities
to be sold in a Future Offering and the price per New Security is determined, the Company will notify the Investor of that information
and the Company will sell to the Investor, if the Investor notifies the Company on or before the thirtieth (30<SUP>th</SUP>) calendar
day after the final closing of such Future Offering (the &ldquo;Offering Response Date&rdquo;) of its intention to purchase, a number
of unregistered shares of the Company&rsquo;s common stock not in excess of an amount sufficient to maintain or reobtain the Investor&rsquo;s
ownership percentage of 19.99% of the Company&rsquo;s outstanding common stock (the &ldquo;Investor&rsquo;s Percentage Ownership&rdquo;);
provided, however, that the Investor&rsquo;s purchase shall be completed within six (6) Business Days after the Offering Response Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.45pt 0pt 5.9pt; text-indent: 36.8pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.45pt 0pt 5.9pt; text-indent: 36.8pt"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.45pt 0pt 5.9pt; text-indent: 36.8pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.45pt 0pt 5.9pt; text-indent: 36.8pt">In addition, the Company and the
Investor hereby agree that, effective upon the Investor Holder Consent (as defined below), the Participation Right, subject to the Waiver
and modification contained herein, shall be extended from December 31, 2023 to such date that the holders of two-thirds of the outstanding
units of the Investor agree (the &ldquo;Investor Holder Consent&rdquo;) to extend such holder&rsquo;s existing agreement that he/she/itwill
have no right to force a redemption of his/her/its interests in the Investor (the &ldquo;Participation Right Extension Date&rdquo;); provided,
however, that the Investor provides written notice to the Company of the Investor Holder Consent prior to December 31, 2023 and the Participation
Right shall in no event extend beyond the Final Expiration Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 8pt 0pt 6.25pt; text-indent: 36.3pt">The Waiver is limited to the matters
expressly waived herein and should not be construed as an indication that the Investor would be willing to agree to any future modifications
to or waiver of any of the Notice Requirement or the Participation Right. Except as expressly set forth above, the terms and conditions
of the Agreement shall remain in full force and effect and each of the Company and the undersigned reserves all rights with respect to
any other matters and remedies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company agrees to reimburse the Investor for
documented expenses incurred by it in connection with the negotiation of this Waiver and such purchases of unregistered sales under the
Waiver up to a maximum of $25,000. The Company further agrees that, in the event the Company sells convertible debt, preferred stock,
or other instruments that are at any time convertible into or exercisable or exchangeable for common stock in a transaction that closes
prior to the expiration date of the Participation Right as set forth in the Agreement, as modified herein, then the Company will reasonably
endeavor to enable the Investor the ability to maintain or reobtain up to the Investor&rsquo;s Percentage Ownership by having the opportunity
to purchase a portion of such securities at the same terms as other investors, on a timeline similar to that specified above for a Future
Offering, whether public or private; provided, that such new securities would not fall within the definition of Excluded Securities and
any such sale does not require the Company to bear any undue legal, regulatory or expense burden or to unreasonably delay any such financing
in order to effectuate such sale.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.45pt 0pt 0; text-indent: 36.3pt">This agreement includes the entire
agreement of the Investor and the Company with respect to the subject matter hereof and supersedes all prior agreements and understandings,
oral or written, with respect to such matters; provided, however, that this waiver does not in any way modify the waiver entered into
between the Company and the Investor on December 18, 2020. This agreement shall inure to the benefit of and be binding upon the Investor
and the Company and their respective successors and permitted assigns in accordance with this agreement. This agreement may not be amended,
modified or supplemented, and no provision of this waiver may be waived, other than by a written instrument duly executed and delivered
by a duly authorized officer of each party hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.45pt 0pt 0; text-indent: 36.3pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD></TD><TD COLSPAN="2" STYLE="text-align: left">Very truly yours,</TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 50%">&nbsp;</TD><TD STYLE="text-align: left; width: 3%">&nbsp;</TD><TD STYLE="text-align: justify; width: 47%">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD COLSPAN="2" STYLE="text-align: left">clirSPV LLC by</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD COLSPAN="2" STYLE="text-align: left">GPCLIRSPV LLC, managing member</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">By:</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: justify">/s/ Robert T. Hoffman Sr.</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD COLSPAN="2" STYLE="text-align: left">Robert T. Hoffman Sr.</TD></TR>
     </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.45pt 0pt 0; text-indent: 36.3pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD COLSPAN="2">ACCEPTED AND AGREED TO:</TD><TD STYLE="text-align: justify">&nbsp;</TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 3%">&nbsp;</TD><TD STYLE="text-align: left; width: 47%">&nbsp;</TD><TD STYLE="text-align: justify; width: 50%">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD COLSPAN="2">ClearSign Technologies Corporation</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>By:</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: left">/s/ Colin James Deller</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD COLSPAN="2">Colin James Deller, Chief Executive Officer</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
     </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.45pt 0pt 0; text-indent: 36.3pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>5
<FILENAME>tm2217097d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.1</B></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"><IMG SRC="image_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ClearSign Technologies Corporation </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Announces Proposed Public Offering of Common
Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Tulsa, OK. May 26, 2022 &ndash;ClearSign Technologies
Corporation (Nasdaq: CLIR) (&ldquo;ClearSign&rdquo; or the &ldquo;Company&rdquo;), an emerging leader in industrial combustion and sensing
technologies that improve energy, operational efficiency and safety while dramatically reducing emissions, today announced that it is
proposing to sell shares of its common stock in an underwritten public offering.&nbsp; All of the shares in the underwritten public offering
are to be sold by ClearSign. ClearSign intends to grant the underwriter a 30-day option to purchase an additional 15% of the shares of
common stock offered in the public offering at the public offering price, less the underwriting discount. ClearSign intends to use the
net proceeds from the offering for working capital, research and development, marketing and sales, and general corporate purposes. The
final terms of the offering will depend on market and other conditions at the time of pricing, and there can be no assurance as to whether
or when the offering may be completed, or as to the actual size or terms of the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Newbridge Securities Corporation&nbsp;is acting
as the sole book-running manager of the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">The shares described above are being offered
by ClearSign pursuant to a shelf registration statement previously filed with and subsequently declared effective by the Securities and
Exchange Commission (&quot;SEC&quot;).&nbsp; A preliminary prospectus supplement relating to the offering has been filed with the&nbsp;SEC&nbsp;and
is available on the SEC's website at&nbsp;http://www.sec.gov.&nbsp; A final prospectus supplement describing the terms of the offering
will be filed with the SEC. The offering will be made only by means of the prospectus supplement and the accompanying base prospectus,
as may be further supplemented by any free writing prospectus and/or pricing supplement that the Company may file with the SEC. This press
release shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall
there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to
registration or qualification under the securities laws of any such state or jurisdiction.&nbsp; Copies of the preliminary prospectus
supplement, and accompanying base prospectus relating to this offering, may be obtained from&nbsp;Newbridge Securities Corporation, Attn:
Equity Syndicate Department, 1200 North Federal Highway | Suite 400 | Boca Raton, FL 33432, email: syndicate@newbridgesecurities.com,
telephone: (877) 447-9625.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About ClearSign Technologies Corporation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ClearSign Technologies Corporation designs and develops products and
technologies for the purpose of improving key performance characteristics of industrial and commercial systems, including&nbsp;operational
performance, energy efficiency, emission reduction, safety and overall cost-effectiveness. Our patented technologies, embedded in established
OEM products as ClearSign Core&trade;, and ClearSign Eye&trade;&nbsp;and other sensing configurations, enhance the performance of combustion
systems and fuel safety systems in a broad range of markets, including the energy (upstream oil production and down-stream refining),
commercial/industrial boiler, chemical, petrochemical, transport and power industries. For more information, please visit&nbsp;www.clearsign.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Cautionary note on forward-looking statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This press release contains forward-looking statements regarding the
proposed public offering and the intended use of proceeds from the offering. The offering is subject to market and other conditions and
there can be no assurance as to whether or when the offering may be completed or as to the actual size or terms of the offering. Forward-looking
statements involve known and unknown risks, uncertainties and other factors that could cause actual results to differ materially, including
those risks disclosed in the section &ldquo;Risk Factors&rdquo; included in the preliminary prospectus supplement filed with the SEC on
May 26, 2022. ClearSign cautions readers not to place undue reliance on any forward-looking statements. The Company does not undertake,
and specifically disclaims any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as
they occur.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>For further information:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Investor Relations: </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Matthew Selinger</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Firm IR Group for ClearSign</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">+1 415-572-8152</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">mselinger@firmirgroup.com</P>
<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"><B>&nbsp;</B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>6
<FILENAME>tm2217097d1_ex99-2.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.2</B></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"><IMG SRC="image_002.jpg" ALT=""><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ClearSign Technologies Corporation </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Prices Underwritten Public Offering of Common
Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Tulsa, OK. May 27, 2022 &ndash;ClearSign Technologies
Corporation (Nasdaq: CLIR) (&ldquo;ClearSign&rdquo; or the &ldquo;Company&rdquo;), an emerging leader in industrial combustion and sensing
technologies that improve energy, operational efficiency and safety while dramatically reducing emissions, today announced the pricing
of an underwritten public offering of&nbsp;3,640,000&nbsp;shares of its common stock at a price to the public of&nbsp;$1.11 per share,
for gross proceeds of&nbsp;$4,040,400. The Company has also granted to the underwriters a 30-day option to purchase, at the same price
per share as the underwriters paid for the initial shares, an additional 546,000&nbsp;(15%)&nbsp;shares to cover over-allotments in connection
with the offering, which if exercised in full would increase the gross proceeds to&nbsp;$4,646,460.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">The offering is expected to close on or about&nbsp;June
1, 2022, subject to customary closing conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">ClearSign intends to use the net proceeds
from the offering for working capital, research and development, marketing and sales, and general corporate purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Newbridge Securities Corporation&nbsp;is acting
as the sole book-running manager of the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">The shares described above are being offered
by ClearSign pursuant to a shelf registration statement previously filed with and subsequently declared effective by the Securities and
Exchange Commission (&quot;SEC&quot;).&nbsp; A preliminary prospectus supplement relating to the offering has been filed with the&nbsp;SEC&nbsp;and
is available on the SEC's website at&nbsp;http://www.sec.gov.&nbsp; A final prospectus supplement describing the terms of the offering
will be filed with the SEC. The offering will be made only by means of the prospectus supplement and the accompanying base prospectus,
as may be further supplemented by any free writing prospectus and/or pricing supplement that the Company may file with the SEC. This press
release shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall
there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to
registration or qualification under the securities laws of any such state or jurisdiction.&nbsp; Copies of the preliminary prospectus
supplement, and accompanying base prospectus relating to this offering, may be obtained from&nbsp;Newbridge Securities Corporation, Attn:
Equity Syndicate Department, 1200 North Federal Highway, Suite 400, Boca Raton, FL 33432, email: syndicate@newbridgesecurities.com, telephone:
(877) 447-9625.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About ClearSign Technologies Corporation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ClearSign Technologies Corporation designs and develops products and
technologies for the purpose of improving key performance characteristics of industrial and commercial systems, including&nbsp;operational
performance, energy efficiency, emission reduction, safety and overall cost-effectiveness. Our patented technologies, embedded in established
OEM products as ClearSign Core&trade;, and ClearSign Eye&trade;&nbsp;and other sensing configurations, enhance the performance of combustion
systems and fuel safety systems in a broad range of markets, including the energy (upstream oil production and down-stream refining),
commercial/industrial boiler, chemical, petrochemical, transport and power industries. For more information, please visit&nbsp;www.clearsign.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Cautionary note on forward-looking statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This press release contains forward-looking statements regarding the
proposed public offering and the intended use of proceeds from the offering. The offering is subject to market and other conditions and
there can be no assurance as to whether or when the offering may be completed or as to the actual size or terms of the offering. Forward-looking
statements involve known and unknown risks, uncertainties and other factors that could cause actual results to differ materially, including
those risks disclosed in the section &ldquo;Risk Factors&rdquo; included in the preliminary prospectus supplement filed with the SEC on
May 26, 2022. ClearSign cautions readers not to place undue reliance on any forward-looking statements. The Company does not undertake,
and specifically disclaims any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as
they occur.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>For further information:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Investor Relations: </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Matthew Selinger</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Firm IR Group for ClearSign</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">+1 415-572-8152</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">mselinger@firmirgroup.com</P>
<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"><B>&nbsp;</B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>clir-20220526.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWa6FebOdzZR+2YkxtmBybYnq/yYpuIT+iCa4UXyGwUED -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:clir="http://clearsign.com/20220526" elementFormDefault="qualified" targetNamespace="http://clearsign.com/20220526">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://clearsign.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="clir-20220526_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="clir-20220526_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" />
    <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
    <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>clir-20220526_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>clir-20220526_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://clearsign.com/role/Cover" xlink:href="clir-20220526.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://clearsign.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !- 5(# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBD- #)
MIHX8FED8*B#+,>PK-TK7;;5)98D!1U)*JW5E]17->)=:^VSFT@?_ $>,\D?Q
MM_@*Q(9I+:=)H6*2(=RM7D5\Q<:J4%>*W\S"56TM-CU:BL[1]5CU6R$JX61>
M)$]#6C7JPFIQ4H[,V3NKA1115#"BC-&: "BC-% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4449H **,TF: %HHJ.>>*V@>:9PD<:EF8] !0!)15:Q
MO[;4K..[M)1)#(,JPJS0 4444 %%%% !1110 4444 %%%% !7-^+=:^P6@M(
M6Q<3CDC^%?7\>E=!+*D$+RR$*B*68GL!7DDMS<^)O$)\H9DN),(#_ @_P'-*
M47*+2(F[*R-;P[H[:Q=[G!%K$?WC?WC_ '175Z]H$=_9 VJ*EQ"N(P!@,!_#
M_A4LLMCX5T$%CB.(8 _BD<_U-8?AGQFVH7[VFH%$>5B8&' '^P?Z&LH86"@U
M8244N5F%I&KR:/J0D8$)G9,AZX_Q%>GQRI+&LD;!D8 J1W%<-XYT;R3_ &M;
MK\K$+.!V/9OZ&KG@/5_M=E)I\C9DM_F3/4H?\#_.JI4O9JRV"'NOE.PJGJ6J
M6FDV;75[*(XE_-CZ =S5MB I). !DFO%/%.O2:[J\DNX_98B4@3M@?Q?4UTT
MJ?M';H5.7*C8U7XC:C<NRZ;&EK#V9AN<_P!!6"WBK7&?<=7N=WLX'Z5TOA/P
M*E_;QZAJH;R7YB@!P6'JQ]/:N\CT'28HO*33;4)Z>4*W=2E!\J5S-1G+5L\Q
MT_Q_K=FX\^1+R+NLB@'\&%>CZ#XDL?$%N7MF*3)_K(7^\OO[CWK!\1> ;*Z@
MDGTJ,6UTHR(Q]R3VQV-5?!O@RZL;J+5-0D>"50?+MT/.#_?/]*B?LI1YEHQQ
MYT[,L>.O$.IZ)=V26$ZQK*C%P4#9((]:U/!.JWFL:&]S?2B243,F0H7@8]*Y
MCXH?\?\ IO\ UR?^8K;^&W_(LO\ ]?+_ -*)17L4[ F^>QV%%,EEC@B>65U2
M-!N9F. !7":K\2X896BTNU\\#CSI254_0=3^E8PA*?PFCDEN=]FBO*4^)>L"
M3+6]FR_W=K#]<UUOA_QQ8ZU(MM*AM;L_=1CE7^A]?:JE1G%7:)4XLZFBDS5'
M5M9L]%LS<WLH1.BJ.6<^@'>LDKZ(LOT5YE>_$V\>0BQL88X^QF)9C^6 *+'X
MFWB2@7]E%)%W,.58?@>#6WU>I:]B/:1/3:*X'5/B0MM=A+&TCN;=HU=9#(5.
M3U!&."*Z_1=0;5='M;YHQ&9TW%0<@5$J<HJ[&I)NR+]%>?S?$>:'59+1M/B$
M:3F(R&4\ -@GI^-4M2^)=X;MQIUM"+=20IE!+./7@\5:H3?07M(GI;.J*68A
M549))P *\6\8?&YH+F6R\,0QR!"5-[,,J3_L+W'N:ZCXEZM?0?"B>Y($%S=K
M%'($)^4.1N _#C\:\-\!:+9>(/&FG:;J#A;61B77./,VC(3/OBML/2CRN<];
M&-:I*ZA'J3S?$7QG?2,_]NWON(0% _!14UA\4O&6G2@C69)PO6.Y17'X\9_6
MOINRTK3]/MUM[.RMX(5& D<8 K(\1^!O#_B:U:*^L(UE(^2XA4)(A]01U^AI
MK$T]G#03HSW4M3DO!'QBLM?N8M-UF%+&_D(6.13F*5NPYY4GT-;?Q+NKB+1;
M>&/<(9IL2L/89 /U/\JS/ _PDL/"]])J&H2IJ%XCG[,2F$B7L<'^/W[=JUOB
M1XH'A3P['<OIT-^D\XA:&9L#!!.>A]*S?)[5>S1HN;D]\S/AA=3E[^UY:V4+
M(#V5SQC\17HU>=?"_P 9IXIBOX(='M].BM-A"PON#%L]>!Z5V^JZO8Z)ITVH
M:C<);VL0RSN?R ]2?2LZR?M&K:ETVN6]R]17AVM_'N<SM'H>E1B$<":\)RWO
MM7I^)K.L/CSKT4X-_IMC<0Y^81;HV ]CDC]*M86JU>Q#Q%.]KGT%17D6M_'&
MUM;;3[C2+!+M+E&,T<TA1X'! VD 'ZY[UW7@SQ-)XJ\*0:S););O*7'E*Q8#
M:Q'7\*SE2G&/-)%JI&3LF='17BVG_'2XN]:MK&;1K>&*6X6)YC<G"*6P6Z=A
MS3?$GQV,-Y);^';"*:)"5^U7).']U48X]R?PJ_JU2]K$^WA:]SVNBO M)^/.
MK0W"C5M,M9[<GYC;Y1P/;)(/Z5[7H>NV'B+28=2TV<2VTHX.,%3W4CL14U*,
MZ?Q(<*D9[&E11161H<MX^OVL_#$B(V'N76+\.I_05E_#G2A%93:O.!NERD1/
M9!U/XG^5+\3]W]F6&WIYS#\=O%6/$=S_ ,(_X#@LX#MDEC2W4CJ,C+'\LUT1
M7[M175F;^)M]#C?%OB%]<U9O*8_8X"4A7U]6_'^58(E<$$$@@Y!!Y!IG:BNM
M025D8-MNYZ]X7U>/Q1X?DMKS#3HODSK_ '@1PWX_SKB=$,WAWQY':2L<"8P,
M?[RMT/\ *JW@W4VTSQ+;,6Q%.?)D';!Z'\#BN@\<VGE>+])N8Q\T[(#CU5Q_
M0UARJ,W'HT:7ND^QV?B6X:U\,ZC,APRP, ?J,?UKQC2+1;W6+*T;[LLRH?IF
MO;-<M#?Z'?6J_>DA8+]<<?K7AUC<M8ZA;W04[H)5?;]#R*,-\+L.INCW]555
M"J  HP .PIU06EU#>VD5U X>*50ZL.X-3UQFP48HI 00"""#T(H \U^*'_'_
M *;_ -<G_F*VOAM_R++_ /7R_P#2L7XH?\?^F_\ 7)_YBMKX;_\ (LO_ -?+
M_P!*ZI?P$9+^(S&^(^MR/=1Z/"Y$:*))\?Q$]%/MWIO@OP=;ZC:#4]20R0N2
M(8<X# ?Q'_"L#QD&_P"$NU'?G.\8^FT4EGHGB2YM(IK.&[:W<9C*38&/89K5
M1M323L1>\KM7/4;GPEH5U 8FTV%!C :-=K#Z$5Y5XCT.7P]JQMR[-&P\R&7H
M2,_S%6_^$=\6_P#/O??]_P#_ .O4<GA7Q--CS;&YDQTWR!L?F:5-<CUE<<G?
MH>C^#];;6= 6:X<&X@)CF;U(_B_$5YCXCUF;7M;DGRS1!O+MXQV7.!^)KK?"
MNDZKI.C:ZEW:O!YD&8]Q')"MZ5QGALQ#Q%IAEQY?VA,YZ=>/UI4XQ4I202;:
M29W^@?#^QM[6.;5H_M%RXR8B2$3VXZFK>J^ ='O;=A:1"SG ^5XR=N?<>E=9
M17,ZLV[W->2-K'S]>6DUA>S6ERFV:)MK#_/:O9?!_P#R*6F_]<1_,UYW\0/+
M_P"$MEV8W>4F_'KC_#%>B>#_ /D4M-_ZXC^9K>O+FIQ9G35I-'D&JJ6UR]4=
M6NG SZEC7IUGX T6*SA6>*26<;6:8N02?ITQ7F>H?\C%<_\ 7XW_ *'7NZ?<
M7Z4Z\I)1LPII-NYB^+?#T?B?PO>Z.[B,S)^[<CA'!RI^F17RMJ^BZOX8U,V^
MHV\UI<1ME)!D D=&1AU^HK[%JO=6EI?PF&[MX;B/NDJ!A^1K.C7=+3=!5HJ>
MO4^9-.^+/C+3XUC75%N47@"YB5S^?!KHK'X]:Y$0+[2[*X7N8V:,_P!17J-[
M\,/!M\2TFA01L>K0DQG]#7*:Y\"]'GM9'T6[N;2Y"DHDS^9&Q]#GD?7-;>UP
M\MXV,O9UH[,Z3P?\3M$\73"TBWV>H$9%M/CYO7:PX/\ .L/X[_\ (EV?_7ZO
M_H+5X#%/<:7J"3Q,8KFUEW*5/*LI_P#K5[K\:+@WGP[TFY(P9KB*0CZH33=%
M4ZL7'9@JKG3DGN9G[/\ ]_7OI#_[-7/_ !F\3S:MXK;2(Y"++3<+M!X:4C+,
M?IG'YUT'[/WW]>_[8_\ LU>9>.%D3QSKHESO^V2YS]:N$4\1)OH1)M44CT3X
M:_">TUC3(M;\0*[03?-;6BL5W+_>8CGGL!7?:I\)?!^H6301:8ME+C"36S$,
MI^A.#^-=-X;D@F\,Z5);8\EK2+9CIC:*U*XYUJCFW<Z84H*-K'Q]XH\.W?A7
MQ!<:3>$,\>&211Q(AZ,/\]:^@OA!_P DPLO]Z;_T-J\]^/4D#>*M-2/'G)9G
MS<>A;Y<_K7H7P@_Y)?8_[TW_ *&U=->3G0C)F-**C5:1\UO&\U\T4:EI))2J
MJ.Y+8 KZ#\-_!;P_9:=$VMQ/?WS*#+F0K&A]% (Z>IKQ#PXH;QOI:D9!U&//
M_?P5]?4\74E&RB["P\(N[9X1\3?A9IVA:*^N:$)(XH6'VBV9BX"DXW*3R,$C
MBJWP)UJ6W\27FCLQ-O=0F95["1,<_B"?R%>K?$O_ ))QKO\ U['^8KQ/X*_\
ME'@_Z]I?Y"E"3G0ES:V'**A5CRGTM1245P'687C#2'U?P]-%"NZXB(FB'J5[
M?B,UROC^;[9H6BW49S$^2?8E1^O!KTFLG6- M-5TF>Q8>6KMYBLH^X_J/Q_G
M6M.IRM7Z$2C=,\.HK1U;0M0T2<Q7D#*N?EE7E&^AK/56=PB*68]%49)_"O03
M35T<]B:S5GO[94SO,J 8]<BO6-3L?[6\::< ,PZ=&9I3C^)C\J_7C-8?@SP;
M<0W4>JZG'Y9CY@@;KG^\WI["O0(X$B+E% +MN8]R:XZU1<WNFT(Z:DAKR?QQ
MX8DTV]DU*UC)LIVW/@?ZICUS[&O6*;)&LL;(ZAD88*L,@BLJ=1P=T7*/,K'C
M7ASQ=>^'_P!SM%Q9L<F%C@J?53V^E=K'\2-$:+<Z7:/W3R\_KFF:K\.-/NY&
MEL)FLW/)3&Y/P'45AGX8ZINXOK,CU(8?TK=NC/5Z&:YXZ(;K_P 0;C4('M=-
MA:VB<8:5C\Y'H,=*E^'VHZR]Y]CB!FTY/]89#Q%_NGU]JO:=\,H4</J-\90.
ML<*[0?Q/-=Q9V-MI]LEM:0I#"G15&*F<Z:CRP0XQDW=G$?$VPEEM;._12R0E
MDDQ_"&Q@_F*R?!/BNUT6*2PO\I!))O28#(0G@Y]O>O4I8DGA>*5%='&&5AD$
M5Q%]\-;26_BEL[@PVQ<&6!N?E[A3_C2A4BX<DQRB[\T3/^(.D>>8=>L\2P2(
M%E9.1_LM].WY54\'>,H]'@_L_4 QM<DQR*,F//4$>E>H?9XOLX@\M?)V[-F.
M-O3&*XK5?AM:7$C2Z;<&U)Y\IEW)^'<4X5(N/),3BT[Q-R3QEX?CA\W^TX6&
M.%7)8_ABN+U'XC7SZHLNG(J6D?'E2KDR^Y]/;%.7X8ZGOPU_:!?4!B?Y5TVA
M>!=.T>1;B4F[NEY5Y!A5/LOK[FC]S#7</??D;FFW,VH:7#/=6C6SRIEH7.2,
MUXWXBT>;0M:EMR&$9;? _JN>/Q']*]QQ5#5M&LM:M#;7L0=>JL.&0^H/:LZ5
M7DEY%3CS(Y/0/B':/:I!K!:&=1@S!2RO[G'(-6]5^(6DVMNWV!S>3D?* I5
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D0JJ,!0, "EQ2USU:LJCNS>G34%9!1116184444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !- 5(# 2(  A$! Q$!_\0
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M7DEY%3CS(Y/0/B':/:I!K!:&=1@S!2RO[G'(-6]5^(6DVMNWV!S>3D?* I5
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D0JJ,!0, "EQ2USU:LJCNS>G34%9!1116184444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>image_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !O 5D# 2(  A$! Q$!_\0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%-DD2&)Y975(T4LSL<!0.I)["@ DDCAB>65U2-%+,[' 4#J
M2>PKQG6]:U3XLZZ_ASPZ[V_AVW8&]OL$"7G^7'RKWZGIP:WK>J?%C7'\.>')
M'M_#\# WM\00)1G^7'"]^IX''JN@:!IWAK2(=,TR 101CD]6=N[,>Y/^>* %
MT+0M/\-Z1#IFF0"*WB'U9V[LQ[D^O]*Y?XO:3_:OPZU JN9+,K=)Q_=/S?\
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M 5\T_"7_ )*U']+C_P!!-?2U?-/PE_Y*U']+C_T$T ?2U%%% !1110 4444
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M_P#]=8?_ $8M 'E7P<\+CQ%XH^VW@,EAI0$HC;E3*Q.P8]."WU ]:^E*\C^
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M^H1-'?7!YW*PY12>=O/XGD]@.=^#EW-I-]KW@R]<F;3[AI8<]USM;'MG:?\
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M "3._P#^NL/_ *,6@##^ '_(K:I_U^_^R+7K=>2? #_D5M4_Z_?_ &1:];H
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M@ZM9(254<SQ#DK[D=1^([UE?!CQ[_:%HOAC4YLW<"_Z'(Q_UD8'W/JO;V^E
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MPR\,:CX2\*OINIF$SFY>4>2Y8;2%QS@>AH [.BBB@ KR7X__ /(J:9_U_?\
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C;Q=X)\8-?Z1<6ESIN\H\<DQ1IH3V8;<!AU!]1Z&O:* /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139943143034936">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>May 26, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 26,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-35521<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CLEARSIGN TECHNOLOGIES CORPORATION<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001434524<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">26-2056298<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">WA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">8023
E. 63rd Place<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 101<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Tulsa<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">OK<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">74133<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">206<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">673-4848<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CLIR<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>tm2217097d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="clir-20220526.xsd" xlink:type="simple"/>
    <context id="From2022-05-26to2022-05-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434524</identifier>
        </entity>
        <period>
            <startDate>2022-05-26</startDate>
            <endDate>2022-05-26</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2022-05-26to2022-05-26">0001434524</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2022-05-26to2022-05-26">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2022-05-26to2022-05-26">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2022-05-26to2022-05-26">2022-05-26</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2022-05-26to2022-05-26">CLEARSIGN TECHNOLOGIES CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2022-05-26to2022-05-26">WA</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2022-05-26to2022-05-26">001-35521</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2022-05-26to2022-05-26">26-2056298</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2022-05-26to2022-05-26">8023 E. 63rd Place</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2022-05-26to2022-05-26">Suite 101</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2022-05-26to2022-05-26">Tulsa</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2022-05-26to2022-05-26">OK</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2022-05-26to2022-05-26">74133</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2022-05-26to2022-05-26">206</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2022-05-26to2022-05-26">673-4848</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2022-05-26to2022-05-26">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2022-05-26to2022-05-26">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2022-05-26to2022-05-26">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2022-05-26to2022-05-26">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany contextRef="From2022-05-26to2022-05-26">false</dei:EntityEmergingGrowthCompany>
    <dei:Security12bTitle contextRef="From2022-05-26to2022-05-26">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-05-26to2022-05-26">CLIR</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-05-26to2022-05-26">NASDAQ</dei:SecurityExchangeName>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>15
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M1S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$%     @ E(B_5)>*NQS
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M7F=Z_S!YU!Y:YU;*O8=7LN48<?R>Y0]02P,$%     @ E(B_5"0>FZ*M
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M8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " "4B+]4^1V(/.\    K @  $0
M            @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " "4
MB+]4F5R<(Q &  "<)P  $P              @ '- 0  >&PO=&AE;64O=&AE
M;64Q+GAM;%!+ 0(4 Q0    ( )2(OU3,SWB 0@0  +T0   8
M  " @0X(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " "4
MB+]4GZ ;\+$"  #B#   #0              @ &&#   >&PO<W1Y;&5S+GAM
M;%!+ 0(4 Q0    ( )2(OU27BKL<P    !,"   +              "  6(/
M  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( )2(OU2JQ"(6,P$  "("   /
M          "  4L0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " "4B+]4
M)!Z;HJT   #X 0  &@              @ &K$0  >&PO7W)E;',O=V]R:V)O
M;VLN>&UL+G)E;'-02P$"% ,4    " "4B+]499!YDAD!  #/ P  $P
M        @ &0$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"
(  #:$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2217097d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://clearsign.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="tm2217097d1_8k.htm">tm2217097d1_8k.htm</File>
    <File>clir-20220526.xsd</File>
    <File>clir-20220526_lab.xml</File>
    <File>clir-20220526_pre.xml</File>
    <File>tm2217097d1_ex1-1.htm</File>
    <File>tm2217097d1_ex10-1.htm</File>
    <File>tm2217097d1_ex5-1.htm</File>
    <File>tm2217097d1_ex99-1.htm</File>
    <File>tm2217097d1_ex99-2.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>20
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "tm2217097d1_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "tm2217097d1_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "clir-20220526_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "clir-20220526_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "clir-20220526.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "clir",
   "nsuri": "http://clearsign.com/20220526",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm2217097d1_8k.htm",
      "contextRef": "From2022-05-26to2022-05-26",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://clearsign.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm2217097d1_8k.htm",
      "contextRef": "From2022-05-26to2022-05-26",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://clearsign.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>21
<FILENAME>0001104659-22-066648-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-22-066648-xbrl.zip
M4$L#!!0    ( )2(OU0BR0 =/ ,  /@+   1    8VQI<BTR,#(R,#4R-BYX
M<V2U5M]3&C$0?FYG^C^D]^J$XT!L1="Q6!QFL'9 K/K2"7<+9@S)F>0$^M<W
MN1^ <"!@>T^YW>_[LIOL[EWM;#)BZ 6DHH+7':]0=!!P7P24#^M.KXO/NXU6
MRT%GIY\^(O/4/F.,FA184$47PL<M/A GZ <9015= @=)M) GZ):PR%I$DS*0
MJ"%&(0,-QI'L5$65@E?N(XRWT+T%'@C9Z[1FNH]:AZKJNN/QN,#%"QD+^:0*
MOAAM)]C51$=JIE:<%--G._H55?Z,?$#.*^,ODPZ]&P+_&K5)^<'_18Z:T+\.
M_CQT#DKW3Q,]^C;MW_-G=WH?1JV; ]H@A[V[Z>6X]_TBV;*F_$<8$60N@ZNZ
M8_-+TQN7"T(.W5*QZ+EW5^UNC',28'7"*'_*@WO'Q\=N[,V@*\A)7[),NNQ:
M=Y\HF"D;+]V IUQIPOU7^$#/"(O@BILX7T%I+O0H@=(,&L 23H%?&(H7US@,
MON0]'V;02.$A(>$,/B"J'\NFCAB.BQXN>QE%2;T*-\9\*-;3$%0N(7'ET'Q&
MY8SA,R"F^(?<%JH%EXJ5TI%I-P8CX+HIY.@"!B1B)JKGB# ZH! X2!,Y!&TK
M3X7$A[?DLOHEG M3YJ;74HNUA2$U=6P,'VKVPJM2,+@QL2.[, VV1MQZW88P
M4\)!-*@[R=+*&-%8*( !Y33>+6TE#V';.)%-S2QC2LU=!B](1 J":WX:KT,)
MRO#B\-O&D!)3R!J23Y@?L=TX\U!R*:DA.Z;YP67MTH$!BMNL:DN@[BAJ!YV3
MVAXE#.J.+0*<W<]ODUK!%$<&L=(;VBP^^>732#?.)(CT5U16QH 1$2%(34V=
M+O1Z$CK5EOYS81MD]U$.<O]%RHST=TW94(#]QUS;5G\QR;1#W'F+I._+;50S
MZ0JI$5]IR$U#,AGO;>''4ALH]@UG/&Q-V"N9B5*8J& >Z2Y!S$]@MR RWAY!
MK!W5>1&H]02[Q,ERVZTWCOV-V^<R76!:918\U]HGG-6/Q#OBB<7V".C590=:
MNE;(2A>M3FE#4&\QXW>U5XGX(N):3N,,MRR214KV$A_'SC>S_,'?[E(R5G(A
M]A_@'<61_PNQ;R#K2Z/F)IIF^1=02P,$%     @ E(B_5&V'L-W_"@  ;(<
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M.K=< #;;8&BB@,BP.P/0J,2H4",A]P;''4\VF.\72=33;9A"MWA 1MM\Z*J
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M:!Z R="'B!1DLA>L,M W7PL2;45_N9\>KY9)GMI./$V)L_X),%?W3EIZ$'P
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M<L,1_JF?%,SM\-0Y2X;F& R4C=SVW6K \1%X,<&@< /BN'M&'RE!'#2KZ>9
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MR+-T!:].M_]0P<I9VZ:M+X:HC6<?G@Y7#Y/QR*Q/,IN!<FG,Q*@7[%H_=OW
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M1GXE&2NM;ZDR[ZAO"P0H<#^?"9/P,AM5-)?*43%]W=QS$#8+AS4 U[B-4>P
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M I)U+K:MZ6/2NTGT_> T(IS<>(1CIZX)I*)@-6.GS"E.3_.8+:U+[AJ0<!,
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MF*2R0<RB='9.(N\K.:5,&JO:8IWH $G!BEG&02_[Y$DL,3B:@!).!%%"*M7
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M9#)8#.Q('8AD[_&6?X;Z'1 (_N$N$'PK@> ?[@+!W]).O*8A='0XT!+Z![*
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M8UR'N6>]0+"90UGXCN-D-DIC,:;QUD:&UW7\$V3O@5_F7"/CIR_CWLT6]Z:
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ME":=G1?45DB[^@Z\;+MLYZ4<;UM.>UO_7+L3W\8>+./J1[#N26AMJ&&H9T*
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MV2IR0!3BEC0*%@L!I7V8@%8LSP1G#-'&E#9AMEAS(%NQ*[HSK"&R\)P?-5+
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M7SRS7(A-FPY=\YES56[M<6UAS^!5LXEH>E.A50_Y1>@G*D)!JZ>-S?'HF5W
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MYKCW;TLTJCW3Q;$QFA2OQ,A6\_K90L]"/?@CM$5-FMKX2(GG(UFT5-_^) 0
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M=IWD3:85>1/NQ0#588:+Y<^5&2Y%*%"^.L-E&;60XF[M+9&,5&=:/]:!NO:
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M$VRUH^9^[$;2LUOK/XE_\>)J=7O+8Y3%])U4?O&PQX/%SI(Y L?53GNXK?W
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MB?Y\0=!Z;YAFYT#SOD64F*Q9?\)B9?VUE:)E9Q2N2NZ^XWP\HHQ-OZ'8@$D
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M@V6,H^N9W4?L4/R1Y,74+;K5C+N(@51(= J_K-5^IA/*':K3E<9.KNVG,E4
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M8CMAZ,"=1'RAUBC/L?E T)<%_GGUW./(D&PZ"^+&@Y6962:D[%J2#FF>.B!
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M!STMIK3NGX.]WO;V=G,^.BHR=ENI)==.#[L.A>KQ06T2=0%0';%,XZ9(!5B
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MCTY/\^MOU.Z +61H9C2T\],!&ZLT%&DK4%'$$RWV6?ZI8;TS&%WF FY%:F3
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MGX[>O6X00M;:_%A%X3=HV@("K;;%C0)0MF4^"MV[L.WDG?;N-SL6HI=B?WW
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M$Y>.F[;IL*L[_4J'9/\-4$L#!!0    ( )2(OU0VK3D/L@D   L>   6
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MZ*R7LG91D),095U"=SL!F@ +=R4F40*NW<,P;"Q0P"$P/ !S%Y+K)='U8M3
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M9^M&"_YUYSU:0-;YO7M\$<_OZW\'4$L! A0#%     @ E(B_5"+) !T\ P
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M,#DW9#%?.&LN:'1M4$L! A0#%     @ E(B_5"<?D%JYO@  6EL$ !4
M         ( !.C$  '1M,C(Q-S Y-V0Q7V5X,2TQ+FAT;5!+ 0(4 Q0    (
M )2(OU0LA&DD" X  .,V   6              "  2;P  !T;3(R,3<P.3=D
M,5]E>#$P+3$N:'1M4$L! A0#%     @ E(B_5"#76QJ<"P  *RL  !4
M         ( !8OX  '1M,C(Q-S Y-V0Q7V5X-2TQ+FAT;5!+ 0(4 Q0    (
M )2(OU0VK3D/L@D   L>   6              "  3$* 0!T;3(R,3<P.3=D
M,5]E>#DY+3$N:'1M4$L! A0#%     @ E(B_5.9AC&\C"@  MA\  !8
M         ( !%Q0! '1M,C(Q-S Y-V0Q7V5X.3DM,BYH=&U02P4&      D
,"0!7 @  ;AX!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
